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This study was designed to investigate some of the
properties of the erythrocyte membrane in human muscular dystrophies.
Physico-chemical properties of the erythrocyte membrane
were investigated. Echinocyte and stomatocyte formation did
not reveal any major alterations in the deformability of the
erythrocyte membrane in Duchenne muscular dystrophy. Osmotic
fragility was increased in erythrocytes from patients with Duchenne
muscular dystrophy. Results from carriers, however, were normal.
(Na+, K+) ATPase is one of the enzymes involved in the
Na+ and K+ pump systems of the cell. The basal activity of the
enzyme was studied, as well as the response to ouabain, a cardiac
glycoside, in erythrocyte ghost membranes from healthy controls
and patients with muscular dystrophies. (Na+, K+) ATPase activity
was lower in patients with clinically confirmed Duchenne muscular
dystrophy, and the response to ouabain was also altered. The
results from carriers were less conclusive. However, this effect
appeared to be specific to Duchenne muscular dystrophy. Control
erythrocyte ghost membranes, subsequent to incubation in Duchenne
plasma, also exhibited an altered response to ouabain, characteristic
of Duchenne muscular dystrophy (Na+, K+) ATPase. This confirmed
the existence of a possible 'circulating plasma factor1 in
Duchenne muscular dystrophy.
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The muscular dystrophies are a group of genetically determined
myopathies, characterised by progressive degeneration of voluntary
muscle. The term 'myopathy' applies to any disorder with signs
and symptoms attributable to a primary pathological, biochemical
or electrical change in the muscle fibre or in the interstitial
tissue of the voluntary musculature.
Extensive studies of the muscular dystrophies began in the
mid 19th century, with the classical descriptions by Duchenne (1868),
Leyden (1876), Hutchinson (1879), Erb (1884) and Landouzy and
Dejerine (1884). These investigators relied on clinical features
when diagnosing the specific types of myopathies, although familial
tendencies were observed. The primary abnormalities which gave
rise to the characteristic degeneration of muscle fibres remain
unknown, and some form of classification is necessary for prognosis
and genetic counselling. Both genetic and clinical criteria are
used for the classification of the muscular dystrophies. Walton
and Nattrass, in 1954, constructed a fairly comprehensive scheme
of classification which, with some recent modifications, is
still in use.
a) X-linked muscular dystrophy
Severe (Duchenne type)
Benign (Becker type)
(Emery - Dreifuss type)
b) Autosomal recessive muscular dystrophy
Limb-girdle type
Childhood muscular dystrophy (except Duchenne)
c) Facioscapulohumeral muscular dystrophy
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d) Distal muscular dystrophy
e) Ocular muscular dystrophy
f) Oculopharyngeal muscular dystrophy
g) Congenital muscular dystrophies
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Clinical description of the muscular dystrophies
a) Duchenne muscular dystrophy
Duchenne muscular dystrophy (DMD) is inherited as an X-linked
recessive trait. The disorder affects young males and, in rare
occasions, girls with Turner's syndrome and other X chromosome
aberrations. The gene is transmitted by apparently healthy carriers.
Clinical onset is normally between the ages of three and five,
although occasionally as late as the seventh. There is symmetrical
involvement of the muscles of the pelvic girdle, and later of
the shoulder girdle. The earliest symptom is often clumsiness
in walking with a tendency to fall, which is followed by difficulty
in climbing stairs and rising from the floor. Pseudohypertrophy
of the calves is usually present at this stage. These physical
signs often seem to regress, but this is usually due to growth
outstripping degeneration. However, the relentless progression
of the disease leads to an inability to walk about 5 years after
onset. When the patient becomes partially immobilised in a
wheelchair, skeletal deformities and muscular contractures are
inevitable. Death is usually in the late teens or early twenties,
due to respiratory infections or cardiac failure.
Recent estimates of the incidence of DMD range from 180
to 330 per 1 000 000 live born males. Approximately one third
of these cases will have a positive family history.
Becker muscular dystrophy
This is the more benign form of X-linked muscular dystrophy.
Onset is usually between the ages of five and 25 years. There
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is a gradual progressive weakness and wasting of the pelvic girdle
muscles, with the later involvement of the pectoral muscles, and
often calf pseudohypertrophy. Twenty five years or more after
onset the patient becomes unable to walk. There is usually no
cardiac involvement, and contractures and deformities associated
with immobilisation are rare. This muscular dystrophy is often
compatible with a normal life span (Emery and Skinner, 1976).
The gene can be transmitted from affected males through their
carrier daughters, to their grandsons.
The incidence of Becker muscular dystrophy is estimated
to be 17.7 per 1 000 000 live born males.
Emery - Dreifuss muscular dystrophy
This is another benign form of X-linked muscular dystrophy.
Onset is usually between the ages of four and five years, with
weakness of the pelvic girdle musculature. The pectoral girdle
musculature is involved at a later stage. The disease is very
slowly progressive. Flexion contractures of the elbows often occur.
The distal muscles are not affected, even late in the disease,
and there is no pseudohypertrophy of the calf muscles. This
muscular dystrophy is compatible with a normal life span (Emery
and Dreifuss, 1966).
>
b) Limb-girdle muscular dystrophy
This type of muscular dystrophy is expressed in either sex,
and transmission is usually as an autosomal recessive trait. Onset
is commonly in the second or third decade, with the primary
involvement of either the muscles of the shoulder or pelvic girdle.
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Weakness usually spreads to the other girdle muscles after a
period of time. There is variable severity and rate of progression,
but severe disability is usually present 20 years after onset.
Skeletal deformauties and contractures are rare, but do occur in
some cases late in the disease. Most patients become severely
disabled in middle life, and normal life span is reduced. The
limb-girdle type is one of the most variable categories of muscular
dystrophies. Transmission in rare cases appears to be as an
autosomal dominant trait. There is considerable variation in
severity from case to case, which often results in the misclassification
of other types of muscle disorders in this group.
The estimated incidence is 46.8 per 1 000 000 live births.
Childhood muscular dystrophy
In general, this type of muscular dystrophy is similar to
DMD, but is more benign. Proof of autosomal recessive inheritance
is difficult in most cases, except where consanguinity has occurred,
but the occasional occurrence of muscular dystrophy in a girl
suggests a distinct category for this type. Onset is usually
between the ages of two and 14 years, with progressive muscle
weakness leading to an inability to walk in the early twenties.
Normal life span is reduced. The weakness is proximal and
hypertrophy is frequent.
Incidence is estimated to be 29.6 per 1 000 000 live births.
c) Facioscapulohumeral muscular dystrophy
This type of muscular dystrophy is characterised by expression
in either sex with transmission as an autosomal dominant trait.
6
Occasionally there is an apparent sex limitation in some families.
Onset is at any age from childhood into adult life, but usually
in the second decade, with the primary involvement of facial
and shoulder girdle muscles, with weakness subsequently spreading
to the pelvic girdle. Hypertrophy is rare, as are muscular
contractures and skeletal deformaties. This type of muscular
dystrophy is compatible with a normal life span, although in rare
cases progression is unusually rapid.
The estimated incidence is 9.2 per 1 000 000 live births.
d) Distal muscular dystrophy
The muscles of the hands, feet and legs are involved in
this benign disease, with weakness spreading proximally. The
age of onset ranges from 20 to 77 years, and severe disability
can occur 10 to 15 years after onset. Transmission appears to
be as an autosomal dominant trait. The true status of the distal
myopathies remains obscure.
e) Ocular muscular dystrophy
The involvement of the external ocular muscles in any
of the other muscular dystrophies is extremely rare. However,
ocular weakness has been described; the clinical symptoms begin
with ptosis, and progress to complete bilateral ophthalmoplagia.
The muscles of the face, neck, trunk and limbs, especially the
arms, are often involved. The inheritance of this type is
usually autosomal dominant and there is indecision as to whether
this is a true muscular dystrophy.
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f) Oculopharygeal muscular dystrophy
This type is probably a distinct entity from the ocular
type, onset is in middle age with progressive dysphagia a prominent
feature. Inheritance is believed to be as an autosomal dominant trait.
g) Congenital muscular dystrophy
Muscle hypotonia is present in these cases at birth. The
severe muscle weakness can be rapidly progressive, leading to
death after six months. There is little definite evidence of
autosomal recessive inheritance, although sibs are often affected.
The borderline remains obscure between cases of congenital and
childhood dystrophy, and later in life these cases are often
of the limb-girdle type with primary involvement of the pelvic girdle.
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Duchenne muscular dystrophy
The Duchenne type is the most common and also the most
severe of the muscular dystrophies. There is intellectual
retardation in about one third of the patients (Emery et al., 1979).
Karagan and Zellweger (1978) also reported verbal disability in
patients with DMD, which they suggested was related to the physical
influence of the disease rather than the psychosocial factors.
There is usually cardiac involvement, which may not, however,
be obvious in the early stages of the disease. Chronic cardiac
failure is rare. The characteristic electrocardiogram (ECG)
shows tall R waves in the right precordial leads, and deep Q waves
in the limb leads and the left precordial leads. Emery (1972)
considered that this ECG pattern may be of diagnostic value in
distinguishing between various juvenile forms of neuromuscular
disease. Perloff et al., (1967) reported pathological changes
in the muscle of the left ventricular free wall. Sanyal et al., (1978)
found ultrastructural alterations in the heart muscle of two
patients with DMD, at autopsy. There was loss of thick and thin
myofilaments and accumulation of mitochondria, as well as dilatation
of the sarcoplasmic reticulum, and depletion of the glycogen particles.
There is no treatment known, at the present time, which
has any definite effect on muscular dystrophy. Many drugs have
been tried with little or no success. Of course, controlled
double blind trials of drug administration are difficult, with
many motivational factors involved. Among those prescribed and
found to be unsuccessful have been vitamin E, corticosteroids,
multiple amino acid and vitamin therapy, adenosine triphosphate, and
anabolic steroids. Many of these have resulted in a reduction
of SCK levels, but muscle power has not been increased. Recently,
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Thomson and Smith (1978) reported that daily prescription of
Allopurinol, which inhibits Xanthine oxidase activity, thereby
preventing purine breakdown, resulted in improved muscle strength
in 16 DMD patients. However, this was not confirmed by Mendell
and Weichers (1979).
A great deal of interest has recently been shown in the
properties of the antiproteinases, which inhibit cathepsin activities.
McGowan et al., (1976) reported that the individual use of the
antiproteinases pepstatin, leupeptin and antipain, delayed embryonic
chick dystrophic muscle degeneration in culture.
Enomoto and Bradley (1977) investigated the effects of
subcutaneous injections of antipain with pepstatin and leupeptin with
pepstatin on murine muscular dystrophy. They reported little success, and
suggested that the antiproteinases were unable to pass through the
sarcolemma into the muscle fibres. The use of liposomes may be of
value in further investigations.
Stracher et al. , (1978), however, found that muscle degeneration
of dystrophic chicks was inhibited by injections of leupeptin with
pepstatin directly into the pectoralis major muscle. This positive
effect was reflected in the ratio of muscle mass to total body
weight, and by different pathohistological changes viewed under
the light microscope, between treated and untreated dystrophic chicks.
However, results from studies on non human tissue must be
viewed critically. There is no true animal model for DMD, either
in the mode of inheritance or in the patterns of muscle degeneration
and regeneration.
Duchenne muscular dystrophy is characterised by progressive
degeneration of voluntary skeletal muscle. The alterations in
muscle fibre structure have been investigated.
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Changes in muscle fibre structure detected by light microscopy
There are a number of histopathological changes associated
with DMD. Muscle biopsy findings vary with the stage of the
disease at which the biopsy was taken, but a composite sequence
of events can be constructed.
There is a marked diminution of total fibre complement,
as well as pronounced variation in fibre size. The marked
enlargement of muscle fibres is an early change. Degeneration
of fibres, as well as necrosis and phagocytosis, are observed,
with muscle fibre regeneration occurring early in the disease. A
characteristic finding of DMD biopsy material taken at this early
stage, is the grouped pattern of regenerating and degenerating
muscle fibres. However, the process of fibre regeneration becomes
less efficient as the disease progresses (Walton, 1973). Considerable
emphasis is placed on the appearance of large, dark, rounded
hyaline or opaque fibres. These have increased enzymic activity
(Dubowitz, 1975). Sarcolemmal nuclei become enlarged, with central
nucleation and subsequent formation of nuclear chains. Proliferation
of perimysial and endomysial connective tissue are also associated
with the histopathological changes in DMD (Engel, 1973). In
the later stages of degeneration, necrosis becomes less active
and hypertrophied fibres are common. During these later stages
of muscle replacement by.an abundance of fat and connective tissue,
DMD is indistinguishable from other chronic myopathies. The almost
total loss of muscle fibres presumably causes the progessive paralysis.
Changes in muscle fibre structure detected by electron microscopy
Milhorat et al., attempted, in 1966, to ascertain the primary
structural lesions which initiated fibre breakdown in Duchenne
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dystrophy, and to correlate these alterations with the changes
in SCK activity. They divided the fibre degeneration into three
sequential stages based on the condition of groups of fibres.
Cullen and Fulthorpe (1975) suggested five stages of fibre
breakdown. This approach is helpful in understanding the fine
structural details involved in each stage, although the disease
is a continuous process and does not occur in the series of discrete steps.
In the early stages of fibre degeneration in DMD, discontinuity
of the Z line becomes apparent. The sarcoplasmic reticulum expands,
and the myofibrils become disorganised. Consequently the intermyofibrillar
space widens and there is an increase in intermyofibri11ar glycogen.
As the degeneration progresses, severe fragmentation of the myofibrils
becomes obvious. Swollen and degenerated mitochondria are found
between the myofibrils, as well as variable-sized vesicles. Some
areas are completely devoid of contractile material. Connective
tissue is found between the fibres. In the late stages of fibre
degeneration, hyaline fibres are found. These are degenerated
fibres containing dark, dense and homogenous contractile material.
Eventually the fibre becomes a mass of structureless cytoplasm
which is invaded by macrophages.
Although electron microscopists have been attempting to define
the earliest detectable morphological change in dystrophic muscle,
the majority have really only added fine details to the known
pathology. Mokri and Engel (1975) described focal defects in the
plasma membrane from patients with DMD. The basement membrane
was always preserved, whilst the plasma membrane was disrupted or absent.
Although these alterations could have been artefacts due to the
method of sample preparation, the authors suggested the alterations
in the plasma membrane were possibly an early and basic lesion.
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Biochemical changes in dystrophic muscle
Cumings, in 1939, reported an altered K+ content of muscle
from one patient with 'pseudohypertrophic muscular dystrophy'.
The K+ concentration was markedly reduced when compared with
controls. This finding was confirmed by Horvath and Proctor
(1958), in patients with progressive muscular dystrophy. This
was probably due to the degeneration of contractile fibres and
infiltration of connective tissue and fat cells, which do not
contain large quantities of K+. This alteration in K+ content,
however, would be non specific to DMD, occurring in many other
degenerative myopathies. The rate of K+ exchange across the
muscle membrane was measured by Blahd et al., in 1953 and 1954.
In cases of childhood muscular dystrophy, the exchange rates
of K+ were very low, and there appeared to be a correlation with
24 hr urinary excretion of creatinine, and with the extent of
physical disability. The authors suggested that as normal muscle
function cannot be maintained with low K+ exchange, this could be
a cause of muscle degeneration. Howland, in 1974, reported raised
K+ conductance in muscle associated with genetic muscular dystrophy.
The addition of a noncompetitive inhibitor of K+ translocation
resulted in a decrease in the level of SCK activity. These findings
also suggested that muscle deterioration may be as a result of
leaking K+.
Enzymic distribution and activity patterns in dystrophic muscle
The majority of muscle enzymes can be expected to show
altered levels of activity in dystrophic muscle. Many changes
will be secondary to the progressive muscle degeneration. Others,
13
however, may represent aspects of a primary metabolic change.
Dreyfus et al., in 1956, published the results of an extensive
study into the enzyme levels of dystrophic muscle. Specimens
of transversus abdominis from muscular dystrophy patients were
compared with the corresponding healthy muscle from controls.
The results were expressed using the non collagen nitrogen as
a reference base. The glycolytic enzymes phosphoglucomutase,
aldolase and oCglucan phosphorylase had reduced levels of activity.
These findings were confirmed by Kleine and Chlond in 1967.
However, Dreyfus et al., (1956) considered these enzyme alterations
to be a secondary defect, as they quoted similar changes in enzymic
activity in experimental neurogenic atrophy. It could be assumed
that decreased activities of enzymes in dystrophic muscle were
due to slow leakage into the blood.
Dubowitz and Pearse (1961) reported no obvious differences
between normal and dystrophic muscle enzyme levels measured
histochemically. Ronzoni et al., (1958) also reported normal
levels of lactate dehydrogenase (LDH) in dystrophic muscle,
despite a marked increase in serum level. Altered electrophoretic
patterns of LDH isozymes, however, have been reported. Wieme
and Lauryssens (1962) found differences in the relative amounts
of the isozymes between healthy and dystrophic muscle. The
major component in human muscle, LDH5, which moves slowest on
electrophoresis, was markedly reduced in dystrophic muscle.
This has been confirmed by other investigators (Emery, 1964;
Brody, 1964).
Pearson et al., (1965) confirmed a reduction of LDH5 in
five patients with DMD and in one patient with Becker muscular
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dystrophy, in the quadriceps muscle, but no reduction was reported
in the gastrcfremius in the case of the Becker patient. Emery (1968)
reported that LDH5 reduction was not specific to any particular
type of muscular dystrophy. The deficiency was probably a
nonspecific concomitant of pathological change in the muscular
system. There appeared to be no effect of storage on LDH5,
which suggested no specific destructive mechanism of the enzyme.
Pennington (1962) reported that adenosine 5'-phosphate
deaminase had a lower activity in dystrophy compared with healthy
muscle. The enzyme, which has been suggested to be involved
in buffering lactate production, occurs in far greater concentration
in skeletal muscle than any other tissues. Cathepsin, an intracellular
proteolytic enzyme, activity was also increased in DMD. Pennington
and Robinson (1968) were able to confirm the increased cathepsin
2+
activity. Increased activity of a Ca activated neutral protease
found in the muscle of five DMD patients, was reported by Kar
and Pearson (1975). The authors suggested a specific role for
this protease in muscle protein catabolism, but the role in normal
muscle remains unknown. These authors confirmed the findings
in 1978, and reported raised cathepsin activities as well, (Kar
and Pearson, 1978).
Haymond et al., (1978) measured mild glucose intolerance
in DMD patients. Plasma glutamine concentrations were not
different from controls. There was a marked decrease in alanine
turnover, which could not be wholly attributed to the reduction
in muscle mass in DMD. The authors suggested this may be
indicative of accelerated protein degradation in the muscle of
patients with DMD. Ballard et al. , (1979) reported that the
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fractional rates of muscle degradation in DMD patients were two
to three times higher than in controls. Protein synthesis was
also increased in DMD.
Another hydrolytic enzyme which has been described as
exhibiting higher activity in human dystrophic muscle is ribonuclease.
Abdullah and Pennington (1968) reported an increased alkaline
ribonuclease activity of muscle homogenates from DMD compared
with controls. This increase may be due to the greater number
of lysosomes in dystrophic muscle. The enzymic distribution in
dystrophic muscle has been reviewed recently by Emery (1977).
Protein synthesis in dystrophic muscle
Mortkton and Nihei, in 1969, reported that dystrophic muscle
contained ribosomes with a far higher rate of activity than normal.
This finding was confirmed by Ionasescu et al., who published
evidence of increased protein synthesis in DMD, in 1971. Incorporation
of amino acids was five times higher in DMD than in controls,
yet the ribosomal content relative to noncollagen nitrogen was
the same. It appeared that the heavy polyribosomes from dystrophic
muscle were capable of producing four to five times more collagen
than those from healthy muscle samples. The extent of the synthesis
depended upon whether a complementary soluble enzyme fraction
was present, from controls or DMD patients. This suggested that
a substance, or substances,in the soluble fraction, which had the
potential to arrest development of connective tissue, was absent
in patients with DMD. The distribution pattern of polyribosomes
on a sucrose gradient was a method of distinguishing between
Becker and Duchenne muscular dystrophies (Ionasescu et al., 1973).
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Distribution of ribosomes in DMD was abnormal compared with those
from controls and Becker muscular dystrophy patients. The supplementation
of dystrophic heavy polyribosomes with the soluble fraction from
control biopsies reduced the level of collagen production to that of
controls (Ionasescu, 1975).
Collagen production by polyribosomes from controls was
enhanced by the addition of the enzyme fraction from DMD patients.
The production of noncollagen proteins by DMD polyribosomes
was increased with the use of diphenylhydantoin and orgotein in
muscle cell cultures (Ionasescu et al., 1979).
Kar and Pearson, however, published their findings of glyoxalase
I activity in 1975. The substrates of the enzyme were believed to
inhibit cell growth with specific action on protein synthesis.
The authors reported a decreased enzyme activity in DMD compared
with controls. This appears to be in direct disagreement with
the findings of Ionasescu.
Neerunjun et al., (1979) reported raised levels of hypoxanthine-
guanine phosphoribosyl transferase (HGPRT) activity in DMD muscle.
This enzyme may be involved with enhanced protein synthesis by
increasing intracellular levels of purine ribonucleotides. High
levels of HGPRT have been associated with rapid cellular growth
and differentiation.
Lipid characteristlcs of dystrophic muscle
The fatty acid composition of infiltrating fat in muscle
from patients with progressive muscular dystrophies has been studied.
Pennington et al., (1966) reported no marked abnormality
in the fatty acid composition of the triglycerides from three
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different muscles at autopsy of a DMD patient. Susheela (1968)
found that the types and concentrations of the fatty acids from
four DMD patients surprisingly fell within normal limits. This
suggested a rapid turnover rate of free fatty acids in the
diseased muscle.
The fatty acid profiles of choline phosphoglycerides have
also been investigated. The increased levels of oleic (18:1)
acid and decreased levels of linoleic (18:2) acid reported by
Takagi et al., (1968) were confirmed by Kunze et al., (1975).
Takagi et al., (1968) also found increased levels of myristic
(14:0), palmitic (16:0) and arachidonic (20:4) acids associated
with choline phosphoglycerides. The exact role of the phospholipid
fatty acids in maintaining the integrity of the membrane remains
unclear, but both reports suggested that the alterations of fatty
acid acylation of choline phosphoglycerides were of specific interest.
Kar and Pearson (1975a), measured an increased activity of
muscle lipase, which rules out the possibility of fat build up
in diseased muscle being due to a defect in that enzyme system.
Increased levels of fat in the muscle are probably due to metabolic
modifications. The swelling of the mitochondria and subsequent
impairment of function could contribute to the accumulation of fat.
Sarcoplasmic reticulum
The early involvement of the sarcoplasmic reticulum in
the degenerative muscle process was suggested by Peter and Worsfold
in 1969. They reported reduced calcium uptake by sarcoplasmic
vesicles in muscle samples from DMD patients. Samaha and Gergely
(1969) confirmed these findings. Takagi et al. , (1973) suggested
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the reduced calcium uptake could be due to a membrane dysfunction,
but they were unable to find any changes in the proteins and
phospholipid patterns, apart from a decrease in choline phosphoglyceride
content. However, major alterations in the sarcoplasmic reticulum
protein profiles were reported by Samaha and Congedo (1977).
They found a significant reduction in the quantity of 100 000
molecular weight protein in DMD samples compared with controls.
This protein contains the ATPase enzyme systems and constituents
of the calcium transport mechanism. Oberc and Engel (1977) and
Bodensteiner and Engel (1978) reported increased abundance of calcium
in degenerating muscle fibres in DMD. It was suggested in both
reports that this calcium accumulation was probably due to abnormal
sarcolemma membrane permeability. The influx of calcium would not
be counteracted by increased sarcoplasmic reticulum accumulation
and there would be precipitation of calcium within active organelles,
which would result in impaired function.
Biochemical changes in body fluids
Serum enzymes
Dreyfus et al., (1958) reported raised levels of activities
of several serum enzymes in patients with progressive muscular
dystrophies when compared with controls. These included aldolase
and pyruvic transaminase. However, Ebashi et al. , showed in 1959
that creatine kinase was a much more sensitive indicator of muscle
damage. Creatine kinase transfers a phosphate from creatine
phosphate to ADP, forming creatine and ATP. Three soluble
isozymes are found; type I (BB) which is found almost exclusively in
the brain; type II (MB) mainly found in cardiac muscle but significant
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activity has been reported in skeletal muscle; type III (MM)
the predominant sources of which are skeletal and cardiac muscles.
Van der Veen and Willebrands (1966) studied the isozyme pattern
in serum from patients with DMD, and found large quantities of
type III, and in some instances type II. This finding has been
confirmed by other investigators (Goto and Katsuki, 1970; Cao
et al., 1971; Goto, 1974; Takahashi et al., 1977; Tzvetanova, 1978;
Yasmineh et al., 1978). Goto (1974) found no relationship between
total SCK activity and the proportion of type II isozyme and
suggested that this reflected type II was released following
heart muscle damage. However, Takahasi et al., (1977), Tzvetanova
(1978) and Yasmineh et al., (1978) did not confirm this and believed
skeletal muscle was the predominant source of isozyme type II.
Values of activity several hundred times greater than normal
are found in early cases of DMD, and the levels of SCK decline
markedly as the disease progresses (Pearce et al., 1964).
Somer et al., (1973) published a comprehensive report of
serum isozyme studies in 22 cases of DMD. SCK isozyme patterns
were similar to those of Van der Veen and Willebrands (1966).
Aspartate aminotransferase was increased, and glutamate dehydrogenase
activity was also raised in later stages of the disease. This
may be an indicator of liver damage, as raised levels of ornithine
transcarbamylase were also reported in several cases. Lactate
dehydrogenase isozyme patterns were also altered. The raised
levels of activity in serum of patients with DMD were due almost
entirely to increases in LDH 1 - 3 isozymes. A marked depression
of LDH 5 was persistently noted. This finding was confirmed by
Hooshmand in 1975.
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Raised levels of pyruvic kinase in serum from patients
with DMD have also been reported by several authors (Harano et al. ,
1973; Weinstock et al. , 1977; Zatz et al., 1978). The majority
of these enzymes are known to be in high concentrations in muscle,
but it is difficult to explain raised serum levels of a number
of enzymes on simple leakage (Pennington,1974).
Kleine (1970) published a comprehensive study, reporting
eleven enzymes which displayed raised levels in DMD sera samples.
Not all these enzymes were specific to muscle, some were released
from liver cells and erythrocytes. Kleine suggested there may
be a generalised enzyme syndrome in DMD. Rosalki and Thomson (1971)
reported a normal level of glutamyl transpeptidase in seven
patients with DMD, which suggested no liver or pancreatic disorder.
Other changes in body fluids
Danowski et al., in 1956, published the results of a comprehensive
investigation into levels of various solutes in the blood of patients
with the childhood type of muscular dystrophy. No changes in
total CO2, Na+, K+, total protein, albumin and globulin were found.
2+
However, levels of Pi and Ca were increased and CI and cholesterol
were reduced. There appeared to be no correlation between these
alterations and the severity of the disease. Garst et al., (1977)
confirmed the unchanged levels of Na+ and K+ in the blood of
patients with DMD. Oppenheimer and Milhorat (1961) however, reported
increased levels of^globulin.
Askansas (1966) identified hemopexin in serum samples from
32 out of 41 DMD patients. Fibrinolytic activity of blood from
DMD patients was also increased (Menon et al., 1971). This may
have been due to leakage from muscle cells, but the authors quoted
increases in other diseases where muscle enzyme leakage was known
not to occur. Myoglobinemia in children with progressive muscular
dystrophy was reported by Ando et al., in 1978. The levels
appeared to be correlated with the age of the patients and serum
levels of CK.
Milhorat (1953) reported increased creatine excretion in
patients suffering from muscular dystrophies. Van Pilsum and
Wolin (1958) confirmed these findings in patients with a variety
of muscular disorders. Measurable creatine excretion in controls
is rare, whereas creatinine can be excreted in large amounts
(1 - 2 g per day). It is generally accepted that creatinuria
is a non specific concomitant of muscle atrophy, which may be
due to the muscle fibres' inability to retain creatine normally.
Hydroxyproline excretion in urine of DMD patients was less than
in controls (Kibrick et al., 1964). Blahd et al., (1955) measured
increased levels of amino acid excretion in patients with muscular
dystrophy. Normal sibs and female relatives of the patients
also showed a high incidence of certain amino acids. However,
Maskaleris et al., (1969) reported that several amino acid levels
were decreased, but the number of the samples were too small for
any significant conclusions to be made. Bank et al. , (1971)
measured an increased taurine excretion relative to levels of
creatine, but no characteristic abnormality of amino acid patterns,
either in urine or plasma, were apparent in 20 patients with DMD.
However, Emery et al., (1979) reported increased urinary excretion
of certain amino acids (ethanolamine, ornithine, leucine) in DMD
patients with mental handicap compared with affected boys with normal
intel1igence.
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Garst et al., (1977) were unable to detect any differences
between DMD urinary excretion of Na+ and K+ and aldosterone,
compared with controls. Di Mauro and Rowland (1976) reported
normal levels of carnitine excretion in 21 patients with DMD.
This was confirmed by Kobayashi et al., in 1979. Lundblad
et al., (1979) have reported increased urine excretion of a glucose
containing tetrasaccharide in patients with DMD. They speculated
that glycogen was leaking out of the muscle cells, which was
then degraded in the blood or urine to give this raised level
of tetrasaccharide.
However, as these reports have suggested, not all muscle
constituents have been found in raised amounts in the serum and
urine of patients with DMD. This could be due to selective
degradation, or the leakage being partially exclusive.
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The pathogenesis of muscular dystrophy
By definition, DMD is an X-linked recessive disorder
characterised by the progressive degeneration of voluntary muscle.
The basic defect, however, remains unknown. There are three main
theories which attempt to describe the pathogenesis of this disease.
The Vascular Theory
Demos published the results of his investigations into
blood circulation in 1961. He reported a delayed arm to tongue
circulation time in patients with DMD. The vascular theory was
developed from this report, with additional evidence from
Hathaway et al., (1970) and Mendell et al., (1971/2). Hathaway
et al., (1970) injected spherical dextran particles and glass
beads into experimental animals, which blocked the microcirculation.
Muscle lesions which werecharacteristic of the histological
pattern of DMD became evident. The authors accepted that although
such similarities did not necessarily indicate a common pathogenic
mechanism, an ischemic defect may be involved. Mendell et al.,
(1971/2) continued with this line of investigation.
However, more recent reports have suggested that there
is no evidence of a structural or functional defect in the
microcirculation of patients with DMD. Morphometric analysis
of the microcirculation has failed to show any quantitative differences
between DMD patients and controls (Jerusalem et al., 1974).
Emery and Schelling (1965) reported that blood flow in patients
was not decreased compared with controls. This finding was confirmed
by Bradley et al., in 1975.




McComas et al., (1971) reported a reduction in the number
of motor units per muscle cell, in extensor digitorum brevis
muscles of patients with DMD. The motoneurones control excitation
and the basic metabolic processes of the muscle fibre. Dysfunction
of the motoneurone would result in an altered metabolism of the
muscle fibre, characteristic of degeneration. McComas et al., (1971a)
introduced the concept of 'sick motoneurones1 which have difficulty
in maintaining satisfactory synaptic connections with muscle
fibres, and suggested that the underlying defect in DMD was neurogenic
in origin. More extensive investigations into other muscles
supported the theory that DMD was a neuropathy rather than a
myopathy (McComas et al., 1974). The failure of neurones from
dystrophic mice to support the functional regeneration of normal
muscle in culture led Gallup and Dubowitz (1973) to agree with
a neurogenic influence. Dystrophic muscles cultured with normal
spinal cord resulted in good myotube formation. The authors
suggested that there may be an aberration in the normal controlling
influence by the nervous system on the muscle.
However, conflicting data have been published which does
not support the theory of a basic neurogenic defect in DMD.
Ballantyne and Hansen (1974) and Panayiotopoulis et al., (1974)
reported finding normal numbers of motor units in DMD muscle.
Nerve endings on dystrophic muscle fibres were also found to be
ultrastructurally normal by Jerusalem et al., (1974a). The absence
of a mosaic pattern in carriers of DMD also suggests the defect
is not neurogenic (Thomson et al., 1974). Sica and McComas (1978)
have published more evidence to support their neurogenic theory and
reviewed the conflicting experimental data.
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Membrane Theory
An impressive amount of evidence has emerged recently which
indicates a primary membrane abnormality in DMD. This membrane
theory, which was reviewed by Rowland in 1976 will be discussed,
in detail, in Introduction II.
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Carrier detection
Duchenne muscular dystrophy is inherited as an X-linked
recessive trait, and is transmitted by apparently normal healthy
female carriers. The genetic carriers are usually classified
into three categories
1) Definite carriers are mothers of one or more affected sons,
who have an affected brother or other male relative on the
female side of the family.
2) Probable carriers are mothers of two or more affected sons
with no other family history.
3) Possible carriers are mothers of one affected son where
there is no other family history, or sisters of an
affected boy.
It is not unreasonable to assume that the characteristic
muscle patterns and raised protein levels measured in the affected
males, should be detectable in the genetic carriersof the disease.
Schapiroet al., (1960) reported raised levels of SCK in carriers
of DMD. Emery in 1963 studied the myopathic changes in two carriers
of DMD, who exhibited raised levels of SCK. Muscle histology
was abnormal, and consistent with the main changes observed in
dystrophic patients. Similar observations in one carrier of DMD
were also reported by Dubowitz (1963). Histopathological changes
were found in muscle biopsies from seven out of nine carriers
(Emery, 1965).
Pearce et al., (1964a) reported their findings of raised
SCK levels in 74 female relatives of patients with DMD. 71%
of the carriers defined as definite on the evidence of a family
pedigree, had raised levels of SCK, compared with 62% of probable
carriers and 50% of the possible carriers.
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Walton and Pennington (1966) studied histopathological
changes in muscle biopsies from carriers, as well as serum
enzyme levels and electrophysiological responses. Raised SCK
levels above the upper limit of normal were detected in 66%
of the definite and probable carriers, whilst 50% of the possible
carriers exhibited increased activity. A proportion of carriers
showed myopathic changes assessed by electrophysiological methods,
but this technique was considered of limited value. Histopathological
changes were apparent in all 8 definite carriers studied, but
alterations were also detected in some of the controls.
Emery (1965a) studied SCK levels, muscle LDH isozyme patterns
and muscle histology in 25 definite and probable carriers of DMD.
By combining the results of these three investigations, 70% of the
carriers were detected. This final assessment could have been
higher as not all the carriers had muscle biopsies.
Gardner-Medwin et al., published a comprehensive report in
1971 of the biochemical, histological and electromyographical
(EMG) alterations in DMD carriers. Their results suggested that
raised SCK levels were the most reliable indicator for carrier
detection. Histological evidence of a myopathic pattern was
often found in carriers, but alterations were uncommon in carriers
where the SCK level was normal. More important, however, was
the frequent absence of changes in carriers with raised SCK levels.
EMG studies were as useful as the histopathological findings.
54% of the definite carriers, 64% of the probable and 20% of the
possible carrier mothers exhibited raised SCK levels. The daughters
of definite carriers were considered separately. 37% had raised
SCK levels as did 14% of the sisters of isolated cases. Craig et al.,
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(1978) confirmed that SCK levels were probably the best single
index for carrier detection. However, they did suggest that a
morphological examination would be useful as an additional
discriminant if the SCK level was borderline.
Age related changes of creatine kinase levels in sera of
carriers of DMD were considered by Moser and Vogt in 1974. The
relationship of falling SCK levels with increasing age of the
DMD patients was well known. Moser and Vogt (1974) suggested
that SCK levels should be measured in possible carriers from
early infancy. This suggestion was repeated by Gale and Murphy
in 1978, who expressed concern at the variation in normal levels
of SCK measured in different laboratories. However, they confirmed
the need to study the effect of age on SCK levels, by repeatedly
sampling carriers and controls over long periods of time.
Nicholson et al., (1979) published their findings that the level
of SCK did indeed drop with increasing age of the carrier, although
individual variations in values were sometimes greater than the
actual reduction in the level of activity. They suggested that
%
the carriers should be tested as early as possible, as there
may be a greater separation of SCK values between normal girls
and carriers at a younger age. However, the distribution of
SCK levels in carriers less than 20 years of age is unknown (Emery, 1979).
Bundey et al., (1979) and Thomson et al., (1979) agreed in principle
with this suggestion but not Carter (1979).
Attention has also been directed on other serum enzyme
levels as a means of carrier detection. Pyruvate kinase has been
studied by Alberts and Samaha (1974) who reported raised levels
in 71% of the definite carriers, whilst SCK was raised in only 29%.
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47% of possible carriers were detected by pyruvate kinase, whereas
only 7% by SCK. The authors suggested that pyruvate kinase was
a better, more sensitive test for detecting DMD carriers. This
finding was not confirmed by Smith and Thomson (1977) nor by
Hardy et ai., (1977). Weinstock et al., (1977) also found that
pyruvate kinase was not as sensitive as SCK, but more carriers
were detected by combining the two enzymic activities rather
than using only one determinant. Seay et al., (1978), however,
found no benefit in combining the levels of SCK and pyruvate
kinase for carrier detection.
Lactate dehydrogenase isozyme patterns have been studied
in serum samples from carriers of DMD. Emery (1964) detected no
differences in carriers compared with controls.
However, Roses et al., (1977) reported that the serum level
of LDH5 was more sensitive than SCK as a test for carrier detection.
Abnormal levels of LDH5 were detected in some of the mothers
of isolated cases. These would usually have been considered
to be possible new mutations. This finding confirmed a previous
report (Roses et al., 1976) that the frequency of new mutations
was lower in DMD than was previously thought. However, Davie
and Emery (1978) failed to support this concept of a lower frequency
of new mutations in DMD. Burt and Emery (1979) failed to confirm
the suggestion that LDH5 was a better indicator of carrier status
than SCK levels.
Askansas (1966a) reported finding increased hemopexin by
an immunoelectrophoretic technique in 70% of the carriers studied.
However, two of the definite carriers were not detected by this
method. Danieli and Angelini (1976) confirmed raised levels of
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hemopexin in carriers of DMD. Raised levels were detected in
33% of the possible carriers who had normal levels of SCK, and
used concomitantly with SCK, 87% of carriers were detected.
Adornato et al., (1978) reported myoglobinaemia in nine
out of 16 carriers of DMD, four of which had normal SCK levels.
However, the authors detected only 78% of the DMD patients using
this method.
Investigations into muscle metabolism have also been carried
out. Ionasescu et al., (1971a) studied polyribosome synthesis
of proteins in carriers of DMD, and reported that in eight out
of 10, increased amino acid incorporation was evident. Only five
had raised SCK levels. This preliminary finding was confirmed
by Ionasescu et al., in 1973, in a follow up study of 63 female
relatives of DMD patients. Ionasescu et al., (1975) suggested
that muscle biopsy findings would be useful in complementing
biochemical and genetic information in carrier detection.
Roses et al., (1976a) used endogenous phosphorylation of
one of the major proteins of the erythrocyte membrane as a marker
to identify carriers. Increased rates of erythrocyte peak 2
phosphorylation were demonstrated. The study included seven
possible carriers whose serum enzyme levels were normal, but
where raised peak 2 phosphorylation was measured.
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Prenatal diagnosis
Toop and Emery, in 1974, suggested that abnormal muscle
histology of foetuses at risk for DMD was apparent in utero.
This was confirmed by Emery in 1977, who reported that DMD could
be diagnosed in the 2nd trimester^ using the parameters of
muscle histology.
Mahoney et al., (1977) reported successful prenatal diagnosis
of DMD using creatine kinase measurements of serum taken from
the placental bed by aspiration. One foetus at risk for DMD
had a low level of SCK measured in this way. The pregnancy,
which went to term, resulted in the birth of an apparently normal,
healthy boy. However, another at risk foetus had an abnormally
high SCK level. At termination of the pregnancy, the foetus
exhibited abnormal muscle histology character!"stic of muscular
dystrophy. Dubowitz et al., (1978) reported the birth of a normal
healthy male to a carrier mother, after measuring the foetal
SCK level using a foetoscope. However, Ionasescu et al., (1978)
Emery et al., (1979) and Golbus et al., (1979) have indicated
that foetal SCK levels are not a reliable test for prenatal
diagnosis. Abnormal muscle histology in at risk foetuses was not
always associated with raised SCK levels (Emery et al., 1979).
Norregaard Hansen et al., (1978) suggested that a radioimmunoassay
of myoglobin in amniotic fluid and serum may be a useful indicator
of prenatal DMD. The protein has a lower molecular weight than
creatine kinase, which may permit easier leakage.
Certainly a prenatal diagnostic test for DMD is of paramount
importance. At the present time carriers receive genetic counselling
with the option of selective termination of male pregnancies. Even
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if the carrier status is definite there is still a 50% chance
that the pregnancy would result in the birth of a normal healthy boy.
Prenatal diagnosis of an affected male foetus is therefore
important, to prevent the termination of pregnancies which could
have resulted in the birth of normal boys. However, as approximately
two thirds of DMD cases have no positive family history, research
into finding the basic treatment and thereby possibly a successful
treatment for the patients is still necessary.
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Membrane abnormalities in Duchenne muscular dystrophy
A great deal of evidence has been published of abnormal
membrane properties of erythrocytes, lymphocytes and muscle fibres,
to suggest a generalised membrane defect in DMD.
Erythrocyte membrane enzymes in muscular dystrophy
Erythrocyte ghost membrane enzymes have been studied in
detail. Brown et al., in 1967, reported an altered response of
the Na+ and K+ dependent adenosine triphosphatase £ (Na+, K+) ATPase]]
enzyme to the cardiac glycoside ouabain. Several groups of investigators
have confirmed this finding, but not all. (This subject will be
reviewed in Chapter 5).
Mawatari et al., (1976) as well as confirming the observations
of an altered response of (Na+, K+) ATPase to ouabain, also reported
abnormal adenyl cyclase activity in patients with DMD. Stimulation
of the enzyme by epinephrine was not apparent in the Duchenne ghost
membranes to the same extent as in controls, and the basal activity
was higher. Das et al., (1976) observed alterations in erythrocyte
acetylcholinesterase and other membrane proteins in DMD ghosts.
Ruitenbeek (1979) although unable to confirm altered (Na+, K+)
2+ 2+
ATPase activity, reported that the Ca stimulated Mg dependent
ATPase enzyme exhibited increased activity in DMD ghost membranes.
Iyer et al., (1976) measured increased phospholipase A activity
associated with DMD erythrocyte membranes. This elevation could be
expected to lead to increased concentrations of lysophospholipids,
which could contribute to membrane dysfunction. Roses et al., (1975)
reported an alteration in erythrocyte ghost membrane protein kinase
in DMD. There was increased phosphorylation of the membrane protein
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spectrin. This was confirmed by Roses and Appel in 1976, Vickers,
McComas et al., (1978), and Vickers, Rathbone et al., (1978) who
also reported increased phosphorylation of other membrane proteins.
However, Iyer et al., (1977), Fischer et al., (1978) and Falk
et al., (1979) have been unable to confirm these findings. These
differences could be partially explained by variations in the
techniques employed to measure protein phosphorylation (Roses, 1979).
Lipid characteristics of the erythrocyte membrane in muscular dystrophy
The lipid constituents of the erythrocyte membrane have
also been studied. Kunze et al., (1973) reported finding an increased
cholesterol content as well as altered patterns of fatty acid
incorporation in ethanolamine phosphoglyceride and sphingomyelin.
In the former, the concentration of arachidonic acid (20:4) was
diminished; in the latter, the concentrations of palmitic (16:0) and
linoleic (18:2) acids were decreased whilst stearic acid (18:0)
was increased. Kalofoutis et al., (1977) found that the amounts
of lysophosphatidyl choline and sphingomyelin incorporated into
the membrane were increased in DMD whereas choline phosphoglyceride
was reduced. Howland and Iyer (1977) reported a diminished amount of
palmitoleic acid (16:1) in the erythrocyte membranes of patients with DMD.
Ruitenbeek (1978) reported no major changes in phospholipid
content, although a reduction in the level of palmitoleic acid (16:1)
was observed. Kobayashi et al., (1978) and Koski et al. , (1978),
however, were unable to confirm any alterations in cholesterol and
phospholipid content, nor any change in the pattern of fatty acid
incorporation.
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Erythrocyte membrane structure in muscular dystrophy
The structure of the membranes of erythrocytes from patients
with DMD have been investigated using freeze fracture techniques
(Wakayama et al., 1978/9). Alterations in the density and
distribution pattern of intramembranous particles were found. In
some cases, the cleaving behaviour of the extracellular face of the
membrane bilayer resembled that of pure lipid. The authors suggested
the observations may be due to altered properties of the intramembrane
proteins, or changes in the nature of the lipid with which they
interact.
Alterations in erythrocyte membrane structure have also been
monitored by saturation transfer electron paramagnetic spectroscopy
by Wilkerson et al., (1979). These results suggested changes in the
protein conformation or organisation within the membrane.
Physico-chemical properties of the erythrocyte membrane in
muscular dystrophy
Many physico-chemical properties of intact erythrocytes from
patients with DMD have been investigated. Matheson and Howland (1974)
reported finding increased numbers of deformed erythrocytes in
samples from DMD patients viewed with a scanning electron microscope.
However, not all investigators have been able to confirm this, and the
subject will be reviewed in more detail in Chapter 3. Yet there is
sufficient evidence in other reports of reduced deformabi1ity of the
erythrocyte membrane to support the theory of a generalised membrane
abnormality (Percy and Miller, 1975; Kohn et al., 1977; Brain et al. , 1978).
Howland in 1974 reported that the rate of K+ efflux from
erythrocytes from DMD was five times higher than that from controls.
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Sha'afi et al., (1975) confirmed the increased efflux in DMD
erythrocytes.
Increased erythrocyte osmotic fragility has also been
observed in muscular dystrophy (Fisher et al., 1976; Lloyd and
Nunn, 1978; Ruitenbeek et al., 1979; Somer et al., 1979). This
evidence will be reviewed in Chapter 4.
The technique of horizontal microelectrophoresis has proved
useful in measuring the electrophoretic mobility of erythrocytes
from patients with DMD (Bosmann et al., 1976). Szibor et al., in 1976
and Szibor et al., in 1979 confirmed altered erythrocytic mobilities
in patients with DMD. They also measured different responses to
ouabain, by incubation with the glycoside of erythrocytes from
controls and patients prior to electrophoresis. In this way they
confirmed the DMD erythrocytes1 abnormal response to ouabain.
Although Solomons et al., (1977) reported an abnormal adenine
metabolism of erythrocytes from patients with DMD, which could
be expected to lead to a reduced viability, Adornato et al., (1977)
found erythrocyte survival was normal.
These erythrocyte abnormalities are summarised in Table 1 .
37
TABLE 1












(Na+, K+) ATPase and ouabain inhibition ^
Adenyl cyclase ^and epinephrine stimulation ^
Phospholipids
Protein kinase (2) ^
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Membrane alterations in lymphocytes in muscular dystrophy
Abnormal membrane properties of other tissues have also been
reported. Verrill et al., (1977) found diminished cap formation
in lymphocytes from patients with DMD. The capping process, studied
with fluorescent antibodies, requires normal membrane fluidity. The
authors suggested that the failure of cap formation reflected some
basic defect in the cell membrane. Pickard et al., (1978) confirmed
the earlier findings, and found that reduced cap formation was not
specific to DMD. Hauser et al., (1979) were unable to detect any
lymphocyte capping abnormality, and questioned the technique used
by Pickard et al., (1978). However, in an extensive series of
cases Horenstein and Emery (1979) have confirmed there is reduced
lymphocyte capping in DMD but this seems to be related to the stage
of the disease and may therefore be secondary to the disease process.
Muscle membrane alterations in muscular dystrophy
2+
Dhalla et al., (1973) measured increased Ca ATPase and
Mg^+ ATPase activities and reduced (Na+, K+) ATPase activity of the
muscle sarcolemma from patients with DMD. Mawatari et al., (1974)
reported a normal level of adenyl cyclase activity, but an abnormal
response to epinephrine and sodium fluoride. The enzyme was
stimulated less, by the two compounds, compared to the stimulation in
controls. Susheela et al., (1975) found that adenyl cyclase activity
was much reduced in DMD muscle compared with controls. Samaha and
Congedo (1977) investigated the proteins of the sarcoplasmic
reticulum. They found, in DMD patients, a decrease in the 100 000
molecular weight protein, compared with controls. This reduction,
which resulted in decreased activity of ATPase, was also divisible
into two categories. One exhibited relatively high enzymic activity,
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the other relatively low activity. The authors suggested on this
evidence, that DMD could be subdivided into two biochemical types.
Mokri and Engel (1975) reported discontinuity in the plasma
membrane of muscle fibres, which they suggested was an early or
basic lesion.
Schotland et al., (1977) using the freeze fracture technique,
found a non uniform distribution of particles in the muscle membrane,
which they considered was an early sign of a membrane abnormality.
Bonilla et al., (1978) studied, with an electron microscope,
concanavalin A binding sites using a peroxidase labeling technique.
Populations of muscle fibres were detected where the reaction at
the cell surface was irregular and patchy. Concanavalin A binds
specifically to c* D mannose, o( D glucose and o<.D fructose residues
on the surface of the membrane. Irregular distribution was obvious
even when the plasma membrane was intact, which led the authors
to suggest the abnormality may precede disruption of the plasma
membrane of the muscle cell and formation of lesions in the muscle fibre.
Erythrocyte membrane structure
The erythrocyte membrane contains a diverse array of enzymes,
transport systems, glycoproteins and proteins of unknown nature
and activity, associated with a lipid bilayer. The interrelationships
of these proteins and lipids are of importance for understanding
the structure and function of the membrane system. There have
been several extensive reviews on this subject, (Coleman, 1973;
Juliano, 1973; Singer, 1974; Steck, 1974).
Erythrocyte ghosts have been utilised to study the properties
of the membrane. Under certain conditions, the ghost closely
mimic the permeability behaviour of intact erythrocytes. They can
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be easily isolated, essentially free of contamination by other
cells. The erythrocyte membranes are prepared by osmotic haemolysis
in dilute alkaline buffers and repeated washings until the ghosts
are pearly white. The proteins can be separated from the lipids
by extraction with polar organic solvents. Approximately 52%
of the membrane mass is protein, 40% is lipid and the remaining 8%
is carbohydrate.
The proteins of the erythrocyte membrane
The polypeptides can be separated from the lipids, and from
one another, by solubi1isation of the membrane in sodium dodecyl
sulphate,and the subsequent polyacrylamide gel electrophoresis.
The proteins can be stained with Coomassie blue and densitometrically
scanned. In this way the proportions can be derived for each major
protein component.
Other components, such as the glycoproteins, are not readily
detected with Coomassie blue, but some can be observed using the
periodic acid-Schiff staining technique. The electrophoretic
mobilities of these species are different from proteins of similar
molecular weights, due to the glycosylated residues.
The major single protein of the erythrocyte membrane is
spectrin. The two subunits of the protein, which are similar but
not identical, have molecular weights of 240 000 and 220 000, and
are bands 1 and 2 after a Coomassie blue stained polyacrylamide gel
electrophoresis separation of membrane proteins. This protein has
been extensively analysed since the report of its discovery by
Marchesi and Steers in 1968. Spectrin dimers are believed to join
end to end to form tetramers, which with other proteins form the
skeletal core of the erythrocyte membrane (Lux, 1979).
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The proteins of the membrane which exhibit enzymic activity ,
are of importance in maintaining the ionic content and integrity
of the erythrocyte. The enzymes can be grouped into two categories
based upon the relationship between membrane integrity and the
expression of enzymic activity.
1. Primarily cytoplasmic enzymes, but which are also associated
with the membrane, are released with haemoglobin. The
activity is expressed in the supernatant after haemolysis,
and there is no effect on the morphology of the ghosts. They
dissociate free of any lipids, and are relatively soluble in
neutral aqueous buffer. These criteria suggest these proteins
are held to the membrane by weak electrostatic forces. The
enzymes of the pentose phosphate pathway, glycolytic enzymes
and adenylate kinase are examples.
2. The integral proteins require far more drastic treatment, such
as detergents, to dissociate them from the membrane. Many of
these enzymes lose their activities when outwith the membrane.
It is not possible to remove them without disrupting the
ghost morphology. The best example of this type is (Na+, K+)
2+




It has been demonstrated that the mechanical and permeability
properties of the erythrocyte membrane depend upon the intracellular
2+
concentrations of Ca and ATP. The metabolic depletion of ATP and
the subsequent accumulation of Ca^+ converts the membrane from an
easily deformable state to a very rigid one. Low intracellular
2+
concentrations of Ca are maintained by virtue of the erythrocyte s
impermeability to the ion, as well as an active extrusion system.
Jarrett and Penniston (1976) reported the partial purification of
a protein activator, Calmodulin, of the Ca^+ ATPase enzyme. The
authors suggested that the modulator protein was the intracellular
2+ 2+
Ca receptor, which stimulated the Ca AlPase. Gopinath and
Vincenzi (1977) confirmed this report and suggested that Ca ions
were necessary for the cytoplasmic activator to bind to the membrane.
Cohen et al., (1978) reported that the modulator protein was very
similar to a subunit of muscle phosphorylase kinase, as well as a
2+
subunit of Ca dependent myosin light chain kinase of smooth
muscle. The protein was also involved with activation of adenylate
kinase, and cyclic nucleotide phosphodiesterases.
Roelofsen and Schatzmann (1977) studied the lipid requirement
2+
of the Ca ATPase enzyme in the erythrocyte membrane. They
concluded that only the glycerophospholipids in the membrane were
involved in the maintenance of enzymic activity, and particularly the
fraction located on the inner half of the membrane.
2+ 2+
The enzyme requires both Ca and Mg for activation. The
2+
Ca stimulated site of the enzyme must be located on the inner aspect
of the erythrocyte membrane.
Na+ and K+ stimulated ATPase
The (Na+, K+) ATPase has been associated with the active alkali
transport system (Dunham and Glynn, 1961). The purified enzyme has
two types of polypeptide chains, the larger of which has a molecular
weight of about 100 000. This protein carries the phosphate
2+ +
incorporated from ATP in the presence of Mg and Na , and possesses
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sulphydryl groups as well as the glycoside binding site. The small
polypeptide has a molecular weight of about 55 000 and is a
sialoglycoprotein. The exact role of this glycoprotein is unknown.
Results from polyacrylamide gel electrophoresis suggest the enzyme
is a complex of two large chains associated with one small chain
(Jorgensen, 1974). The enzyme is believed to span the membrane of the
cell, an idea made more appealing by the fact that almost half of
the amino acids are hydrophobic in nature (Kyte, 1972).
When the alkali cation pump is operating in its usual manner,
three Na+ and two K+ are transported across the membrane for each
ATP molecule hydrolysed. The overall (Na+, K+) ATPase reaction is
believed to consist of three sequential steps. The first involves
the transfer of a phosphate group from ATP to the protein, with
2+ +
the production of ADP. This reaction is dependent upon Mg and Na ,
and is inhibited by ouabain. The second step is the translocation of
the phosphate group to another site, this is inhibited by oligomycin.
The final event is the dephosphorylation of the protein, dependent on
2+ +
Mg and K and is inhibited by ouabain.
Ouabain, a cardiac glycoside, is a highly specific inhibitor








Evidence of a tyrosyl residue at the active site of the
(Na+, K+) ATPase enzyme has been published by Masiak and D'Angelo
(1975). Acetylation of human erythrocytes by N-acetyl imidazole
resulted in loss of enzymic activity. The effect of borate ions
strongly suggests that an arginine residue is also involved
(De Pont et al., 1977)
Freeze fracture studies of the membrane bound (Na+, K+)
ATPase were reported by De Guchi et al,, in 1977. Each surface
particle consisted of one large catalytic polypeptide chain of
molecular weight approximately 100 000. Two such surface particles
were united to form the active unit of (Na+, K+) ATPase which
bound one molecule of ATP and ouabain. The surface particles
protruded from the surface membrane, which suggested the protein
units spanned the membrane and were capable of lateral motion.
The intracellular site bound the (Na+, K+) ATPase antibody




This enzyme requires Mg , and ATP. However, no specific
2+
physiological function has been attributed to Mg ATPase.
Glyceraldehyde 3 phosphate dehydrogenase
The action of ouabain on the (Na+, K+) ATPase system causes
a variation in the rate of alkali cation transport. This is
reflected by variations in the rate of glycolysis of the erythrocyte.
Glyceraldehyde 3 phosphate dehydrogenase, one of the most important
enzymes in the glycolytic pathway, is located on the inner surface
of the membrane, orientated towards the cytoplasm (Schrier, 1977).
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Glycoproteins of the erythrocyte membrane
The major glycoprotein, which can be observed by polyacrylamide
gel electrophoresis and periodic acid-Schiff staining, contains
large quantities of sialic acid residues, which are the main
contributors of surface charge of the erythrocyte. The main
si a!©glycoprotein contains 64% carbohydrate, which includes 28%
N-acetylneuraminic acid. The carbohydrate side chains which stem
from alkali labile linkages, are probably tetramers, which end in
sialic acid. These glycoproteins are known to possess blood group
antigens, and also lectin and influenza virus receptor sites.
Freeze fracture studies have shown that the carbohydrate chains
extend beyond the exterior face of the membrane, whilst the
protein interacts with the other components in the interior of
the membrane to form intramembranous particles (Marchesi et al., 1972).
Lipid composition of the erythrocyte membrane
The lipid, phospholipid and fatty acid composition of
erythrocyte membranes have been investigated (Ways and Hanahan, 1964;
Dodge and Phillips, 1967). The hydrophobic nature of the lipid
bilayer has an effect on the activity of the intramembrane enzymes,
as well as on passive permeability.
Membrane Structure
A great deal of information on membrane structure, particularly
erythrocyte membrane structure, has been collected since 1935 when
Davson and Danielli proposed their theory of the membrane being a
continuous hydrocarbon phase contributed by the lipid components.
The unit membrane hypothesis of Robertson, which extended that of
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Davson and Daniel 1i by including a mononuclear layer of proteins
on either side of the lipid bilayer, no longer explains the structure
of the membrane in such a way as to agree with recent experimental
data. Singer and Nicholson put forward their theory of membrane
structure in 1972. They suggested a fluid mosaic structure analogous
to a two dimensional orientated solution of integral proteins in a
viscous phospholipid bilayer solvent. This model agrees well with
experimental data on the membrane (Figure 1).
In this model it is clear that the nature of the lipids can
exert an effect on the microenvironment of the proteins. Spectrin
tetramers lie attached to the inner surface of the membrane,
providing the skeletal core. Any pertubation in proteins or lipids
will effect the membrane as a whole (Figure 2).
Figure1Dia rammaticalrepresentationofthfluid-mosaicdelofmbraneructur (fromSingerandNicholson,1972).T esolidbodi srepr sentg obular proteinswithinthlip dmatrix.
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CHAPTER 3







The interrelationships between shape, structure and functional
characteristics of normal and pathological erythrocytes have been
under investigation in a variety of genetic disorders. With the
advent of the scanning electron microscope three dimensional
aspects of cell shape can be studied, with increased resolution
and magnification.
The healthy mature erythrocyte, as viewed in the circulation,
assumes a biconcave shape. This is the most appropriate for the
erythrocyte's major function of transporting oxygen to the various
tissues of the body, which requires optimum deformabi1ity and a
smooth profile as well as exhibiting maximum surface area. In
some diseases of the blood the functional characteristics of the
erythrocytes are altered, with associated changes in shape, which
can be detected with an electron microscope. In 1969, Bertles
and Dobler utilised the electron microscope to distinguish between
reversible and irreversible sickling of erythrocytes in sickle
cell anaemia.
By 1972, there was some evidence to suggest altered membrane
properties of erythrocytes in muscular dystrophy. Brown et al.,
(1967) and Araki and Mawatari (1971) reported an altered erythrocyte
ghost membrane (Na+, K+) ATPase. These alterations in enzyme
behaviour of the erythrocyte may affect cell shape. Morse and
Howl and (1973) studied erythrocyte shape in animal models of muscular
dystrophy. The authors, using a scanning electron microscope, reported
a high percentage (51.6%) of the cells from dystrophic mice were
distorted when compared with cells from normal littermates
(4.1%). These irregularities in shape were due to protrusions of
variable size from the cell surface. Similar irregularities
in shape were found in patients suffering from congenital muscular
dystrophies by Matheson and Howl and (1974) who classified
these erythrocytes as 'echinocytes1 (Bessis, 1973). These
echinocytes were also visible under the light microscope
(Matheson and Howland, 1974; Lumb and Emery, 1975), and this
suggests that they were not artefacts due to the methods of
preparation and fixation. Increased proportions of echinocytes
were also found in some carriers of the X-linked Duchenne dystrophy
(Matheson and Howland, 1974; Lumb and Emery, 1975; Grassi et al., 1978).
Lumb and Emery (1975) and Miale et al., (1975) however, doubt
that this would be a more valuable test than SCK for carrier detection.
The preparation of the erythrocytes can induce echinocyte
formation. Matheson and Howland (1974) described that prewashing
the erythrocytes caused an increase in the number of echinocytes.
This was confirmed by Howells in 1976, and could be due to the
stripping of plasma proteins adhered to the membrane. Lumb and
Emery (1975) reported that prewashing the erythrocytes had no
such effect.
However, Matheson et al., (1976) and Soltan (1977) were unable
to detect any significant abnormalities in the shape of the
erythrocytes from patients with DMD. Matheson et al., (1976)
measured the reproducibility of the procedure, not only between
samples but environments as well. They reported great variations
between repeated samples, and were unable to confirm the previous
findings of Matheson and Howland (1974). They advised caution
in the use of this procedure as a diagnostic test for carrier
detection or clinical confirmation of DMD. The morphology of the
cells was very sensitive to the various preparative treatments.
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Another distinct population of erythrocytes was found by
Miller et al., (1976) in myotonic and Duchenne muscular dystrophy.
These erythrocytes were cup-shaped and classified as stomatocytes
(Bessis, 1973). Although the percentage of stomatocytes in samples
from dystrophic patients was very variable (20% - 80%) only
2% - 5% of the erythrocytes from controls were cup-shaped. In
this study the scanning electron microscope rarely showed echinocytes.
More recently Tillman et al., (1979) confirmed increased
echinocytes in DMD, measured by phase contrast microscopy.
In view of the discrepant findings of previous investigations,
and because of the obvious relevance to the pathogenesis of DMD,
the present study was undertaken to determine if significant
morphological abnormalities of erythrocytes in patients with DMD
and in carriers could be demonstrated.
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Materials and Methods
Venous blood was collected (5ml - 10ml) from patients and
their relatives when the families attended the Neuromuscular Clinic
at the Western General Hospital in Edinburgh. Control blood samples
were collected from healthy female hospital staff, with no family
history of any neuromuscular disease. Blood was collected from
young male controls prior to orthopaedic operations unrelated to
any muscular disorder. The samples were studied within four hours
of collection.
The majority of the patients suffered from Duchenne muscular
dystrophy, diagnosed by clinical investigation, confirmed by abnormal
muscle histology observed after biopsy. The female relatives of
the patients were classified into five categories for these
experimental investigations:-
1) Definite carriers - mothers of one or more affected
males who had an affected brother or other male relative
on the female side of the family.
2) Probable carriers - mothers of two or more affected
sons, with no other family history.
3) Possible carriers I - mothers with one affected boy
where there is no other family history.
4) Possible carriers II - sisters of affected boys.
5) Other females relative - aunts and grandmothers.
The patients and relatives are referred to, throughout the
text, by the family number, followed by the generation number,
and personal number within that generation.
The erythrocytes were prepared by a modification of the
method of Matheson and Howland (1974).
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20 jjl of heparinised blood was diluted 10 fold with ice
cold 0.9% saline, washed twice and centrifuged at 1 000 g for three
minutes. 180 ^il of cold gljtfceraldehyde fixative was added and the
cells left at room temperature for one hour, then mixed and left
for another hour, centrifuged and the supernatant removed. The
cells were washed twice in buffered sucrose (10% cacodylate buffer).
They were then dehydrated by suspending sequentially in 25%, 50%,
75%, 100% acetone. These samples were stored in 100 per cent acetone
at 4°C overnight.
The volume of each sample was made up to 10 ml with 100%
acetone, mixed and allowed to stand for five minutes. 2 ml of the
cell suspension was filtered through a millipore membrane (5 pm).
The cells adherent to the membranes were critical point dried,
and coated with gold using the E5000 Diode Spluttering System.
The samples were then stored in a desiccator prior to electron microscopy.
Five different areas of the membranes were scanned and
photographed at a magnification of x3000. The cells exhibiting
the characteristic shape changes associated with echinocyte and
stomatocyte formation (Bessis, 1973) were counted and expressed
as a percentage of the total cell count. All samples were
studied 'blind' without knowledge as to the source of the
material and the code was broken at the end of the study.
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Results
Obvious shape changes were classified into three categories
(Bessis, 1973):-
Echinocytes I
Echinocytes II and III
Stomatocytes
Duchenne patients
The results of erythrocyte deformation in samples from controls,
patients with clinically confirmed DMD and their unaffected brothers
are shown in Table 2 and individual values for patients are given
in Table 3. There was no significant correlation between either
age or SCK value with either percentage of echinocytes or percentage
stomatocytes. There was also no significant difference in percentages
of echinocytes and stomatocytes in affected boys and controls.
Two views of the erythrocytes after preparation as seen
under the electron microscope are shown in Plate 1 depicting
typical scans.
Carriers of DMD
The range and mean of echinocyte and stomatocyte formation in the
controls and the carrier groups are expressed in Table 4. The
individual results for each of the carrier groups are shown in
Table 5. There was no correlation between SCK levels and percentage
echinocytes or percentage stomatocytesin the mothers of the patients.
There was no significant difference in the percentages of echinocytes
or stomatocytes in the possible carriers I and controls. Only
two of the values for echinocyte I formation were outside the
control range, and none for echinocytes II and III. However, the

















































Table 3 Individual values of echinocyte and stomatocyte formation
in patients with clinically confirmed DMD.
Age SCK Echinocytes
Patients (yrs) IU/1 I II+III Stomatocytes
1. 11
3 7 6 000 19.5 3.7 6.5
2. III2 6 18 200 27.3 0.4 2.8
3. II 2 18 310 12.7 0.0 9.3
3. "4 14 2 300 11.6 0.0 14.8
3.
6
11 2 900 15.4 0.4 11.1
4. 11
4
10 2 500 13.8 0.4 17.5
6. 11
6
11 3 500 9.3 0.0 13.7
8. IH1 11 11 500 10.0 0.0 9.2
Plate 1 Control erythrocytes (a) and erythrocytes from a DMD
patient (b) as seen under the scanning electron microscope.


































Table 5 Individual values of Echinocyte and Stomatocyte formation in
carriers of DMD and other female relatives
Age SCK Echinocytes (%) Stomatocytes {%)
years IU/1 I II+III
Definite/Probable Carriers
3. I




32 41.0 24.5 3.3 5.4
2. II 2 29 ' 56.0 24.0 2.1 7.4
41 36.0 9.6 0 18.3
6. I
2 39 82.0 8.7 0 9.8
8. II
3
30 37.0 6.7 1.2 9.1
12. II
4 37 53.0 16.5 0.5 7.5
Possible Carriers II
6. II 2 17 50.0 17.3 0.6 5.6
6. II
3 15 88.5 10.4 0 10.4
6. II
4
14 53.0 11.6 0 2.6













percentage of stomatocytes appeared to be decreased in the sisters
of patients compared with controls but because of the small numbers
no significance can be attached to this.
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Discussion
The results of this study have failed to confirm some of
the previous findings of an increased population of deformed
erythrocytes by scanning electron microscopy in patients with
DMD and in heterozygous carriers. There was no observable
difference between echinocyte formation in pre- or un- washed
erythrocytes. All these observations were made on coded samples
to remove all chances of observer bias.
There are a number of factors involved in the maintenance
of cell shape, some of which may be of importance when discussing
the mechanism of echinocyte and stomatocyte formation. Nakao
et al., (1960) measured the relationship between the levels of
ATP and ADP, and erythrocyte shape. They reported that if the
sum of the two concentrations of ATP and ADP were kept at a certain
level, the erythrocyte assumed a biconcave shape. The erythrocyte
became crenated at lower levels and completely spherical at very
low levels of ATP. The authors, however, were not clear on the
importance of absolute concentrations, or the level of turnover,
of these adenine nucleotides. These results were confirmed by
Weed et al., (1969) who studied the changes in concentration of
ATP in the erythrocyte during incubation in serum. The level of
ATP dropped with incubation, which paralleled a progressive rise
in the calcium level of the erythrocyte and a change in the
viscosity of the red cell suspensions. These changes were reversible
by the addition of excessive ATP, even in the presence of ouabain.
The authors suggested the major role of ATP in the maintenance
of erythrocyte viability was related to the preservation of membrane
deformability, and that calcium ions were also important. Any
condition leading to a diminution of intracellular levels of ATP
61
was likely to result in leakage of enzymes and other proteins,
as the ATP may exert a direct effect in maintaining the integrity
of the cell membrane (Wilkinson and Robinson, 1974).
The protective role of ATP on membrane integrity and
maintenance of cell shape could be mediated by the protein spectrin.
This protein, which is situated on the intracel1ular side of the
membrane, has ATPase activity (Kirkpatrick et al., 1975) and is
capable of lateral movement. It has been described as erythrocyte
myosin, and is postulated to be involved in the maintenance of
cell shape and deformabi1ity. The removal of spectrin from
erythrocyte ghosts causes them to lose their characteristic shape,
and to become spherical and fragile (Elgsaeter et al., 1976).
Sheetz and Singer reported their findings in 1977 on the relationship
between ATP and the spectrin complex, with reference to erythrocyte
shape changes. Intact erythrocytes and ghosts assumed a crenated
shape when depleted of ATP. This change was reversible on incubation
with ATP. Stomatocytes were formed on incubation of erythrocytes
with excess ATP. Magnesium was required for the shape changes,
which were completely inhibited in the presence of calcium. The
addition of ouabain had no effect. The major enzyme involved was
assumed to be the protein kinase of the erythrocyte membrane. The
phosphorylation of the spectrin molecule was postulated to result
in the polymerisation of the subunits on the inside of the membrane.
The ratio of inner to outer surface area would then increase,
with the subsequent formation of a cup-shaped erythrocyte. When
the ratio decreases, with the absence of ATP for spectrin phosphorylation,
the erythrocyte would assume the shape of a crenated sphere. The
shape resulting from a balanced ratio would be that of a biconcave
disc. The importance of this shape for the functional characteristics
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of the erythrocytes rests on two points. Firstly, a biconcave
disc exhibits a greater surface area than a sphere of the same
volume; secondly, the biconcave disc is a less energy utilising
shape than other non spherical forms.
From these results the authors suggested the ratio of surface
areas is very important, and it is in this way that ATP exerts
an effect on membrane integrity. Birchmeier and Singer (1977)
hypothesised that the phosphorylation of component 2 of the spectrin
molecule causes changes in shape, by realignment or polymerisation
of the spectrin subunits. This would cause an increase in the
inner surface area, thereby causing the formation of stomatocytes.
Lux et al., (1978) found that spectrin extraction from ATP
depleted cells was more difficult. They suggested this may have
been due to an increased binding between spectrin subunits, or
between spectrin and integral membrane proteins or lipids. Such
complexes could have resulted from intermolecular disulphide
couplings (Palek et al., 1978).
Antibodies to the spectrin protein have been very useful in
investigating these relationships further. Ferritin conjugated
antibodies have been used to study the distribution of spectrin
along the membranes of normal and echinocytic erythrocytes
(Ziparo et al., 1978). With frozen sections of non haemolysed
erythrocytes, the label of the spectrin antibodies was seen to
follow the contours of the membrane surface, although the distance
from the edge of the membrane varied,probably due to different planes.
It is not known whether the spectrin is bound to lipid directly, or
at some distance from the inner half of the layer. The pattern
for echinocytic cells was identical. No antibodies were found at
the bases of the echinocytic spines. The spiny processes did not
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appear to have been formed by contraction of the spectrin meshwork,
which would have resulted in extrusion of cytoplasm. This finding
is not in agreement with the theory that the ratio of surface areas
is of primary importance (Sheetz and Singer, 1977), as this would
suggest that no spectrin meshwork should be found in the echinocytic
protrusions.
Lin and Macey (1978) suggest that high intracellular levels
of divalent metal ions result in linking of the acidic lipid head
groups, causing echinocyte formation.
The involvement of spectrin phosphorylation and calcium ion
concentrations in hereditary spherocytosis and sickle cell anaemia
have been investigated. Rubin and Rosen (1975) and Matsumoto et al.,
(1977) have reported a decrease in phosphorylation of membrane
proteins in spherocytosis. Lux et al., (1976) reported a defect in
the 'spectrin-actin lattice1, which may be the primary abnormality
of the irreversibly sickled cell. Steinberg et al., (1978)
suggest that rises in calcium concentrations in the erythrocyte
associated with potassium efflux (Gardos effect) may be related to the
sickling process.
The observations on spectrin phosphorylation and metabolism
of erythrocytes in the congenital muscular dystrophies are contradictory.
A reduction of intracellular ATP and ADP levels and a rise
in the concentration of AMP were measured by Solomons et al., (1977)
in cases of DMD and myotonic dystrophy. However, Danon et al., (1978)
reported that intracellular ATP has a higher concentration in
erythrocytes from patients with DMD, and an increased production of
1actate.
The first report of an altered rate of phosphorylation of
spectrin in DMD was published by Roses et al., (1975). Both
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phosphorylation of band 2 and 3 was significantly raised (p < 0.01)
when compared with controls. This finding was not confirmed
by Iyer et al., (1977) who studied protein kinase activity in
three patients with DMD. These authors also found differences
in enzyme behaviour upon freezing and storage, than those published by
Roses et al., (1975). This was due to an altered method of membrane
preparations and assay technique (Vickers, Rathbone et al., 1978).
Vickers, McComas et al., (1978) confirmed the earlier findings of
Roses et al., (1975) of an increased phosphorylation of band 3
protein and spectrin, in patients with DMD and heterozygous carriers.
Vickers, McComas et al., (1978) reported increased rates of
phosphorylation, but the mean increases were not different. The
results of Falk et al., (1979) were similar in that peak 2 phosphorylation
was slightly increased, but with the wide range of values from male
and female controls (which were not considered separately), such
differences were not so clear cut.
The theories which attempt to explain the echinocyte and
stomatocyte formation of normal erythrocytes are interdependent upon
one another. However, it is generally accepted that these deformed
cells do not exist in vivo. The methods of preparation and fixation
of the erythrocytes for study with light and electron microscopes are
capable of inducing the changes which are seen. Therefore, it is
more plausible that erythrocytes from patients with DMD are more
likely to deform under the conditions of preparation, than are
controls. If this can be accepted, the observed discrepancies can
be explained by the different conditions of the preparative techniques.
The mechanism by which the erythrocyte shape does alter could
be due to a generalised membrane defect which becomes apparent
under certain conditions; age or metabolic deprivation may make the
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erythrocytes more susceptible to deformation under the specific









The erythrocyte membrane acts as a barrier between the
cytoplasm and extracellular fluid. There is passive transport of
water, and active transport of other molecules and ions across
this membrane in an attempt to maintain an equilibrium of
thermodynamic energy. This phenomenon of osmosis is necessary
for the cell to maintain its integrity whilst the composition of
the extracellular fluid changes. This occurs continuously in the
blood plasma, with the erythrocyte compensating by intracellular
volume changes. There is an upper limit to which the membrane is
able to expand. This occurs when the extracel 1 ular fluid has a
much lower molecular concentration than the cytoplasm. There is
excessive transport of water into the erythrocyte which results in
cell lysis.
The erythrocyte can regulate the intracellular conditions not
only by enzymic control of active transport but also by expansion
and contraction of the membrane. The extensibility of the membrane
is related to its fluidity and deformabi1ity.
Percy and Miller (1975) reported reduced deformability of the
erythrocyte membrane from patients with DMD. They found that a
greater negative pressure was required to aspirate erythrocytes
from DMD patients into a micropipette, than those from controls. These
findings were confirmed by Kohn et al., (1977) who measured the
visco-elastic resistance to deformation. Brain et al., (1978)
studied the sheer modulus of the erythrocyte membrane, which was
higher in DMD patients than controls. The erythrocytes were subjected
to a negative pressure which caused budding of the membrane rather
than total aspiration. This was a more direct method of assessing
membrane deformabi1ity, rather than involving the cytoplasm as well.
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Sheer modulus is inversely related to deformabi1ity. Butterfield
et al., (1976) however, came to the conclusion that DMD erythrocytes
have normal membrane fluidity, as measured by electron spin labelling.
Fisher et al., (1976) measured the osmotic fragility of
erythrocytes from patients with 'pseudohypertrophic muscular dystrophy1.
They found that erythrocytes from patients with muscular dystrophy
were more fragile than those from controls. This was confirmed
with cases of clinically confirmed DMD by Lloyd and Nunn (1978).
Ruitenbeek et al., (1979) studied the effects of phospholipase
treatment on control, DMD and myotonic erythrocytes. They
confirmed the earlier reports of increased osmotic fragility in DMD
and myotonic dystrophy, and also found that lysis of control
erythrocytes with pancreatic phospholipase could be partially
inhibited. The addition of K and Li ions, or ouabain, or glucose,
2+
or lowering Ca concentration, partially prevented lysis. Somer
et al., (1979) reported increased osmotic fragility in 15 cases of
DMD, but found no significant difference in membrane deformabi1ity
between controls and DMD erythrocytes. They also found that the
erythrocyte volume was lower in DMD than controls. Adornato et al.,
(1977) designed a study to investigate erythrocyte turnover in
the blood. They found that the erythrocyte lifespan was normal,
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measured by labelling the cells with Cr. The osmotic fragility
was also found to be normal. Their results failed to support
the theory of a significant erythrocyte membrane defect in DMD.
A larger study was designed to investigate osmotic fragility
of erythrocytes from DMD patients and carriers, after a pilot study
(Lloyd and Nunn, 1978) indicated some differences.
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Materials and Methods
The osmotic fragility of erythrocytes was determined by
the method of Dacie and Lewis (1975).
A stock solution of buffered sodium chloride was made up,
osmotically equivalent to 100 g/1, pH 7.4.
Serial dilutions were prepared:-
1.0, 3.6, 3.8, 4.0, 4.2, 4.4, 4.6, 4.8, 5.0, 9.0 g/1.
50 ^il of heparinised whole venous blood was added to 5ml
of these saline dilutions and immediately mixed by inversion.
The solutions were left to stand at room temperature for 30 minutes,
then reinverted and centrifuged at 1 000 g for five minutes.
The optical density of the supernatants were determined
spectrophotometrically at 540 nm.
There was no erythrocyte lysis in 9.0 g/1 saline, this
was used as the blank for the spectrophotometer. Complete lysis
was measured in 1.0 g/1 saline.
The lysis at each dilution was expressed as a percentage




The results of studies into the osmotic fragility of erythrocytes
from clinically confirmed DMD patients, their unaffected brothers,
and age matched controls are shown in Table 6. At various concentrations
of buffered saline (from 4.2 g/1 to 5.0 g/1) there was a significant
difference (p < 0.01) between the percentage lysis in DMD erythrocytes
compared with controls.
However, there was an overlap of the individual values between
the DMD samples and controls (Figure 3). The threshold of lysis
was the most sensitive indicator of measurable differences between
erythrocytes from DMD patients, and normal healthy boys. None
of the controls, or unaffected brothers showed any signs of lysis
at 5.0 g/1, whereas at this concentration fragility was detected
in 15 out of the 18 DMD samples studied.
There was no correlation between the amount of lysis in
DMD samples (at 4.2 g/1 and 4.4 g/1) and age or SCK level. This
suggests there was no direct relationship between the severity
and the duration of the disease, and the osmotic behaviour of
the erythrocytes.
At low concentrations of buffered saline (3.8 g/1 and 4.0 g/1)
the differences between unaffected brothers and controls just
reached a level of statistical significance (p< 0.05) but this
was probably due to the wide variation in measured values for
the brothers and the small number involved in the study.
Carriers of DMD
The results of investigations into the osmotic fragility of
erythrocytes from carriers and other female relatives are shown
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Table 6 Percentage lysis of controls, patients with clinically













1.0 100.0 100.0 100.0
3.6 95.5 2.45 94.1 5.03 93.4 6.01
3.8 91.2 2.92 91.1 5.86 83.2* 13.16
4.0 80.1 10.32 84.7 10.38 63.5* 18.40
4.2 50.3 15.09 69.9** 14.55 38.5 11.87
4.4 16.8 11.25 39.3** 18.43 9.6 2.11
4.6 6.3 5.37 18.7** 10.55 4.6 2.07
4.8 1.7 1.76 7.3** 5.22 1.1 0.86







Figure 3a Individual graphs of osmotic fragility of erythrocytes
from patients with DMD. Hatched area represents
mean + 2SD for controls.
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Figure 3b. Graph of osmotic fragility of all DMD patients compared
with controls (mean + 2SD).
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in Table 7. There were no significant differences between controls
and any of the groups of female relatives.
In contrast to the young male controls, 58% of female controls
exhibited lysis at 5.0 g/1 buffered saline. In female controls
there was no correlation between age and lysis.
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Discussion
The results of the present study have shown that there was
a marked increase in the osmotic fragility of erythrocytes from
patients with clinically confirmed DMD when compared with
controls. There was no such difference between female controls
and heterozygous carriers. There was a sex effect between the
amount of lysis in the threshold region (5.0 g/1) exhibited by
male and female controls.
The fluidity and deformabi1ity of the erythrocyte membrane
is determined by many variables. The nature of the lipids is very
important, not only the functional head groups but also the types
of fatty acids associated with them. The strength of lipid and
protein interaction is one of the main determinants of membrane
integrity, thereby controlling the cytoplasmic volume.
The composition and fluidity of the membrane lipids is of
critical importance in the normal functioning and growth of the
cell. If the deformability of the membrane is reduced, the
erythrocytes are unable to undergo the necessary shape changes
whilst they circulate in vivo. The contours of the erythrocyte
become folded, there will be a reduced ability to flow and a
progressive loss in surface area. These erythrocytes will eventually
be destroyed.
The unsaturated nature of the lipids, as well as cholesterol
content are important determinants of membrane fluidity. Cooper (1977)
suggested that cholesterol binding imposes degrees of immobility
on the outer membrane, and thereby increases the freedom of motion
deeper within the membrane core. Blau and Bittman (1978) concluded
from their studies that cholesterol was distributed symmetrically
between the inner and outer halves of the lipid bilayer. Up to
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half of the total cholesterol has been removed fairly easily from
the erythrocyte membrane by incubation in plasma (Gottlieb, 1976;
Lange and D'Alessandro, 1977). Any increase in cholesterol concentration,
which would effect crosslinking between lipids, would change the
permeability characteristics of the membrane. There would be a
decrease in mediated transport and facilitated diffusion of
substances across the membrane (Cooper, 1977).
Any major alterations in the unsaturated nature of the lipids
would also result in permeability changes of the membrane. The first
report of an altered lipid composition of the erythrocyte membrane
in progressive muscular dystrophy was published by Kunze et al., in 1973.
They found that the sphingomyelin content was increased, and the pattern
of fatty acid incorporation of phosphatidylethanolamine was altered.
The unsaturated acids were decreased with a concomitant increase in the
stearic acid (unsaturated) level. The lipid composition of muscle
biopsies were also reported as being altered. The authors related
these changes to the primary defect being the specific incorporation
of linoleic acid (18:2) into phosphatidyl choline during the de novo
synthesis of muscle.
Iyer et al., (1976) studied the activity of erythrocyte
phospholipase A. The membranes from DMD patients exhibited higher
levels of activity than those from controls. This high activity
could be expected to lead to high concentrations of lysophospholipids
in the membrane, which could contribute to membrane dysfunction.
Diphenylhydantoin reduced the level of enzymic activity to normal.
Further abnormalities in lipid composition of the erythrocyte
membrane in DMD were reported by Kalofoutis et al., (1977) who
also found increased sphingomyelin as well as lysophosphatidyl
choline. Howland and Iyer (1977) reported an altered fatty acid
composition, which was obvious in the erythrocyte membranes from
heterozygous carriers of DMD, but more variable in cases of patients.
They also found low membrane triglyceride content, and suggested
that these lipid abnormalities may give some clues to the primary
defect of the disease.
Kobayishi et al., (1978) were unable to confirm these alterations.
When comparing erythrocyte membrane lipids from DMD patients with
age and sex matched controls they reported no differences in total
cholesterol and phospholipid content, or the fatty acid components
of the phospholipids. Koski et al., (1978) also found the DMD
phospholipids normal. They suggested that the discrepancies between
controls and patients that were previously measured by Kunze
et al., (1973) and Kalofoutis et al., (1977) were perhaps due
to lack of precautions against auto oxidation. This could have
resulted in the observed increases in sphingomyelin content.
However, Di Stefano and Bosmann (1977) have studied the
erythrocytes of mice with genetic muscular dystrophy, using the
technique of aqueous polymer partioning. They found measurable
differences between dystrophic mice and their normal littermates.
This technique relies on alterations in the configuration and/or
conformation of primarily lipids, and also proteins, as well as
net organisation changes deep within the membranes, as a means to
distinguish between different membrane systems. Wakayama et al., (1978)
found an uneven distribution of particles on the protoplasmic
and extracellular faces of the erythrocyte membranes from DMD patients,
measured by freeze fracture. In some instances, the cleaving
behaviour of the extracellular face resembled that of pure lipid.
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The authors suggested this may be due to the proteins which constitute
band 3 on SDS gel electrophoresis, having altered properties.
Hidalgo et al., (1978) investigated the effect of the lipid environment
on protein motion and enzymic activity of the sarcoplasmic reticulum
2+
Ca ATPase. Any decrease in lipid fluidity, attained either by
lipid replacement or temperature changes, resulted in inhibition
of the ATPase and reduction in protein rotational mobility. These
results were consistent with the proposal that both protein rotational
mobility and lipid fluidity are essential for enzymic activity.
A decrease in elasticity and deformability resulting in increased
osmotic fragility was measured by Williamson et al., (1975) in
erythrocytes at high temperatures.
The integral membrane proteins are also involved in regulation
of cell shape and membrane deformability. Smith and LaCelle (1979)
reported that the pH induced reduction of membrane deformability
and elasticity was paralleled by a pronounced change in the
solubility of the membrane protein spectrin.
Quantitative observations cf altered phospholipid content of
erythrocyte membranes are contradictory, but the ratio of lipid
to protein may be a more valuable comparison. Although actual levels
of phospholipids, cholesterol and sphingomyelin may be normal, the
protein levels may be altered. This would lead to differences in
specific lipid-protein interactions which would be detectable by
freeze fracture or electron spin resonance (Wilkerson et al., 1979).
Thus, the findings in the present study of increased osmotic
fragility in DMD could be accounted for by the reported reduced
deformabi1ity of erythrocytes; in this disorder probably secondary
to protein-lipid alterations in the membrane. However, osmotic
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fragility of the erythrocytes is not governed solely by the
deformability of the membrane. The surface area to volume ratio
is also of importance. Somer et al., (1979) found that erythrocyte
volume was lower in DMD than controls. They also reported no
differences in deformability measured by microsieving, when taking
the reduced volume into account.
CHAPTER 5
ERTHROCYTE MEMBRANE (Na+, K+) ATPase AND THE EFFECT OF PLASMA







Relatively high concentrations of internal K+ are required
for a variety of cellular processes such as glycolysis and protein
synthesis. If the high internal concentration of K+ were not
compensated by loss of some other cation, there would be a net
increase in the internal osmotic pressure causing the cell to swell
and burst. The active transport of Na+ out of the cell by means
of the Na+ pump leaves the intracellular contents low in this
cation and the extracellular concentration high. This inward
gradient is believed to be the driving force of the active transport
of K+, glucose and amino acids into the cell. The enzyme responsible
for the coupled transport of Na+ and K+ across the erythrocyte
membrane, (Na+, K+) ATPase, is directional in its action.
The action of the cardiac glycoside ouabain supports the
concept of Na+ extrusion driving K+, glucose and amino acid uptake.
This compound specifically inhibits, in normal cells, Na+ transport
out of the cell, which thereby affects the transport of K+, glucose
and amino acids across the membrane.
However, Brown et al., in 1967 reported an unusual response
to ouabain of (Na+, K+) ATPase in erythrocyte ghosts from patients
with myopathies. Their investigations showed that (Na+, K+) ATPase
of erythrocyte ghost membranes prepared from seven out of eight
clinically confirmed cases of DMD had abnormal responses to ouabain.
Consistent stimulation of activity by the cardiac glycoside was
also found in patients described as having 'spontaneous muscular
dystrophy' and myotonia. These results were not confirmed by
Klassen and Blostein (1969) who found no enhancement of activity
by ouabain in seven cases of DMD. Peter et al., in 1969, supported
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the earlier findings of Brown et al,, (1967) in reporting stimulation
of erythrocyte ghost (Na+, K+) ATPase activity by ouabain in 12 out
of 13 cases of clinically confirmed DMD. An altered response of
(Na+, K+) ATPase to ouabain has been confirmed by other investigators
(Araki and Mawatari, 1971; Niebroj-Dobosz, 1976; Mawatari et al.,
1976; Siddiqui and Pennington, 1977; Pearson, 1978) but not by
all (Hodson and Pleasure, 1977; Souweine et al., 1978; Wacholtz
et al., 1979; Ruitenbeek, 1979).
The present investigation was undertaken in an effort to
determine if the reported effects of ouabain could be confirmed
and if so, whether or not this was specific for DMD; or occurred
in other neuromuscular disorders (such as myotonia, facioscapulohumeral
muscular dystrophy, Becker muscular dystrophy, limb-girdle muscular
dystrophy, peroneal muscular atrophy and periodic paralysis).
Experiments were also designed to determine what effect dystrophic
plasma may have on normal erythrocytes regarding (Na+, K+) ATPase
activity and the effect of ouabain.
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Materials and Methods
Preparation of ghost membranes
Erythrocyte ghost membranes were prepared by a modification
of the method of Mawatari et al., (1976).
The packed red cells (10 ml) were haemolysed for 20 minutes
at 4°C in 10 mM Tris buffer (pH 7.4 containing 1 mM NaCl, 1 mM KC1,
1 mM MgCl^, 1 mM dithiothreitol). The lysate was centrifuged
at 10 000 g for 30 minutes, and the separated erythrocyte ghosts
were washed in the same buffer three times. After each centrifugation,
the lysozyme button, which sedimented below the ghost membranes
was removed. All operations were carried out at 2°C to 4°C.
The erythrocyte ghost membranes were resuspended in 0.5 ml - 1.0
of the same buffer and stored overnight at -23°C.
Protein estimation
The protein concentration of the ghost membrane suspension
was measured by the method of Lowry et al., (1951).
Reagent A (see Appendix II) 2% sodium carbonate and
0.5% copper sulphate and 1%
sodium tartrate in 0.1M sodium
hydroxide.
Reagent B (see Appendix II) Folin - Ciocalteu Reagent
Bovine serum albumin stock (see Appendix II)
The ghost membrane samples were thawed, gently homogenised
in a hand-held homogeniser, and then 0.1 ml was dissolved in 0.9 ml
of solubilising fluid.
Bovine serum albumin stock was dissolved in the solubilising
fluid for calibration.
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Each sample was measured in duplicate.
To 1 ml of protein solution was added 5 ml of reagent A,
mixed by inversion and allowed to stand at room temperature for
10 minutes. 0.5 ml of reagent B was then added, immediately mixed
by inversion and the extinction coefficient read at 700 nm after
30 minutes at room temperature. Bovine serum albumin was used
for the standard calibration curve.
Inorganic phosphate estimation
The inorganic phosphate released by the (Na+, K+) ATPase
was measured by the method of Fiske et al,, (1925). Details of the
reagents and proportion are given in Appendix II.
After the addition of 50% trichloroacetic acid (TCA), the reaction
mixture was centrifuged at 1 500 g for 15 minutes. 0.5 ml of the
supernatant was pipetted into a 1 ml graduated stoppered cylinder.
0.1 ml of molybdate 2 was added and mixed. Then 0.04 ml of
aminonaphtholsulphonic acid was added and the solution made up
to 1 ml.
A standard was made up using dilutions of a standard phosphate
stock. 0.1 ml of molybdate 1 was added to 0.5 ml of standard
phosphate and mixed. 0.04 ml of aminonaphtholsulphonic acid was
added, and made up to 1 ml with water. After five minutes the
extinction coefficient was measured at 680 nm. Standard phosphate
dilutions were used for the calibration curve.
Assay procedure for (Na+, K+) ATPase enzyme
The activity of the (Na+, K+) ATPase enzyme was measured
by a modification of the method of Peter et al., (1969).
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All incubations were carried out at 37°C, The incubation
mixture consisted of 0.1 ml of ghost membrane suspension and
1 mM NaCl, 2 mM KC1, 1 mM Mg in 0.1 M Tris (pH 7.4) in a
final volume of 1 ml.
The incubation time and the concentrations of Nag ATP and
ghost membrane protein were varied to optimise conditions for
(Na+, K'1") ATPase activity. Control ghost membranes were used
throughout the following procedures.
(Na+, K+) ATPase activity vs. Na^ ATP concentration
The activity of the (Na+, K+) ATPase was measured at various
concentrations of Nag ATP:-
1, 2, 2.5, 3, 3.5, 4, 4.5, 5, 5.5, 6 mM
After 10 minutes the reaction was stopped by the addition
of 0.2 ml of 50% TCA. The inorganic phosphate released was measured
by the methods of Fiske et al., (1925). The results are expressed
graphically in Figure 4.
(Na+, K+) ATPase activity vs. ghost membrane protein concentration
Various protein concentrations were prepared by dilution
of ghost membrane stock and assayed with 4 mM Nag ATP in the
incubation mixture. After 10 minutes the reaction was stopped with
TCA and the inorganic phosphate measured. The results are expressed
graphically in Figure 5.
(Na"1", K+) ATPase activity vs. time of incubation
5 ml of incubation mixture was taken containing 4 mM Nag ATP
and including a suspension of ghost membranes equivalent to
300 yg ml \ The reaction mixture was incubated at 37°C. At time
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Figure 4 Effect of increasing Na„ ATP concentration on
the activity of (Na+, K ) ATPase
fjmol Pi, mg protein"1, hr"1
Na2 ATP mM
Figure 5 Effect of increasing ghost membrane protein
concentration on the activity of (Na"1", K+) ATPase
jjmol Pi released, hr-1
(jg protein
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intervals 0.5 ml aliquots were withdrawn, to which 0.2 ml of 50%
TCA was added. The inorganic phosphate released was assayed.
The effects are shown graphically in Figure 6.
(Na+, K+) ATPase activity vs. time of storage
Ghost membranes were prepared and divided into 1 ml aliquots,
all except one were frozen and stored at -23°C. The enzymic activity
of the unfrozen sample was measured, and the other samples assayed
at 24 hour intervals. The ghost membranes were thawed and kept
on ice for 30 minutes prior to assay. The enzymic activity was
reduced (7%) after storage for 24 hours. The drop in activity
after storage is shown in Figure 7, expressed as the percentage
loss compared with the 24 hour frozen sample.
(Na+, K+) ATPase activity vs. ouabain concentration
The effect of ouabain, at various concentrations, on the
enzyme was studied
10"6, 10"5, 10~4, 10"3 10"2 M.
The results are shown in Figure 8.
Measurement of the activity of (Na+, K+) ATPase and effect of ouabain
The erythrocyte membranes were stored, frozen at -23°C,
for a maximum of seven days.
The ghost membranes were thawed at 10°C and then stored on
ice for 30 minutes prior to assay. From the results of the above
experiments, assays were carried out under what were considered
optimal conditions:
The incubation mixture consisted of 1 mM NaCl, 1 mM MgCl^,
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Figure 6 • Effect of increasing incubation time on the
activity of (Na', K+) ATPase
pmol Pi released^mg protein-1
minutes
Figure 7 Effect of freezing and storage on the activity
of (Na+, K+) ATPase
hr frozen
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Figure 8 Effect of increasing concentration of
ouabain on the activity of (Na+S K+) ATPase
% Inhibition
icr6 icrs icr4 icr3 icr2
Ouabain M
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2 mM KC1, 4 mM ^ ATP in 0.1 M Tris (pH 7.4) and a suspension of
erythrocyte ghost membrane equivalent to 250 to 350 pg protein,
in a final volume of 1 ml. After incubation at 37°C for 15 minutes,
protein was precipitated by adding 0.2 ml 50% TCA. The inorganic
phosphate released was measured by the method of Fiske et al., (1925)
as outlined earlier.
The enzyme activity determinations were measured in duplicate,
and in two series, one with freshly prepared ouabain added to a
-4
final concentration of 10 M, the other without.
An enzyme blank was assayed with each sample, with 50% TCA
added prior to the incubation.
The enzymic activity was expressed in pmoles inorganic
phosphate released per mg ghost membrane protein per hour (jjmoles
Pi, mg protein-1, hr-1).
-4
The effect of ouabain (10 M) on the enzyme was expressed
as a percentage of the difference between the activity without
and with the addition of the cardiac glycoside
% effect = (activity - ouabain) - (activity + ouabain)
(activity - ouabain)
Coefficient of Variation
100 ml of venous blood was donated by one control on a
particular day, collected into 10 separate heparinised containers,
and the ghost membranes prepared from each of the packed cell
volumes as described previously. The activity of the (Na+, K+)
ATPase enzyme, and the effect of ouabain was determined, and
the 10 separate results compared. The coefficient of variation
(SD/mean x 100) was 3.6%. The coefficient of variation of samples




Individual (Na+, K+) ATPase activities with SCK levels
and ages, are shown in Table 8 for controls and Table 9 for patients.
There was no correlation between the level of (Na+, K+) ATPase
activity and age, SCK or percent effect of ouabain, nor between
the percent effect of ouabain and age or SCK level.
The basal activities are shown in the form of a histogram
in Figure 9. The distribution was normal.
The basal activity of (Na+, K+) ATPase from 20 clinically
confirmed cases of DMD was significantly lower (p<,0.01) than
that from 13 age and sex matched controls (Table 10). Without
exception, the addition of ouabain resulted in stimulation of
enzymic activity in the samples from DMD patients, and inhibition
in the controls.
Female relatives compared with controls
The female relatives were divided into 4 groups as described
previously:-
1) Definite and probable carriers
2) Possible carriers I
3) Possible carriers II
4) Other female relatives
The individual basal activities of the ghost membrane (Na+, K+)
ATPase are expressed in Table 11 for female controls and Table 12 for
carriers as well as the response of the enzyme to ouabain. The
distribution of enzymic activities are shown in Figure 10. Ouabain















Individual values of (Na+, K+) ATPase activity
(pmoles Pi, mg protein \ hr ^), and response
to ouabain in age and sex matched controls.
SCK ATPase ATPase I effect
IU/1 -ouabain +ouabain of ouabain
98 1.30 1.20 - 7.7
49 1.13 1.04 - 8.0
48 1.28 1.20 - 6.3
51 1.52 1.29 -15.1
32 1.66 1.50 - 9.6
58 1.57 1.21 -22.9
36 1.06 0.98 - 7.5
56 1.58 1.37 -13.3
69 1.86 1.75 - 5.9
50 1.40 1.32 - 5.7
64 1.30 1.19 - 8.5
66 1.35 1.22 - 9.6
60 1.50 1.20 -20.0
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Table 9 - Individual values of (Na+, K+) ATPase activity
(pmoles Pi, mg protein \ hr ^), and response to
ouabain in patients with confirmed DMD.
Age SCK ATPase ATPase % effect
Family No. years IU/1 -ouabain +ouabain of ouabain
1. I
3 7 6 000 1.17 1.35 +15.4
2. I *2 6 18 273 1.06 1.18 +11.3
3. I
2
18 309 1.00 1.14 +14.0
3. I
4
14 2 310 1.01 1.08 + 6.9
3. I
6 11 2 900 1.07 1.18 +10.3
4. I
4
10 2 505 0.70 0.82 +17.1
6. I
6
11 3 540 0.68 0.73 + 7.4
8. I !1 11 11 540 1.33 1.58 +18.8
11. I
2
16 1 020 1.47 1.69 +15.0
12. I 12 1 180 1.10 1.23 +11.8
15. I
3
19 290 1.04 1.25 +20.2
16. I 6 3 640 0.87 0.91 + 4.6
17. I
1
7 11 129 1.33 1.39 + 4.5
18. I u 12 1 320 1.18 1.46 +23.7
19. I h 12 3 159 0.86 1.01 +17.4
20. I h 12 1 312 0.88 1.01 +14.8
21. I
1 14 2 430 0.89 1.01 +13.5
22. I !3 12 3 400 0.95 1.02 + 7.4
24. I
2
11 1 180 1.03 1.16 +12.6
25. I
1
17 580 0.94 1.02 + 8.5
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Table10(Na,K)ATPasctivity(pmolesP gpr inhrndrespon etouaba oferythrocyteghostmembranesfrpatientsw thDMD,c mparedagnd sexmatchedcontrols ATPase Age-ouabain+ouab in%Effect MeanSDnea DMD (n=20)11.93.73.00.2 16. 4+ 2.85 5 Controls (n=13)4.53.601 20.227.196-10.85 5 Significanceof differencep<0.001N.S.<0 001
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Table 11 Individual values of (Na+, K+) ATPase activity
(^imoles Pi, mg protein 1, hr ^) and response to
ouabain, in female controls.
Age SCK ATPase ATPase % effec
years IU/1 -ouabain +ouabain of ouab;
23 34 1.18 1.07 - 9.3
18 45 1.56 1.38 -11.5
17 47 2.26 2.11 - 6.6
27 79 2.55 2.19 -14.1
23 52 2.28 2.02 -11.4
17 35 2.29 1.99 -13.1
62 39 1.88 1.79 - 4.8
44 65 1.63 1.36 -16.6
22 55 1.57 1.43 - 8.9
20 39 1.51 1.32 -12.6
38 34 2.15 2.02 - 6.1
26 47 1.40 1.14 -18.6
49 64 2.10 1.86 -11.4
33 53 1.68 1.27 -24.4
46 52 1.89 1.44 -23.8
35 55 1.08 0.76 -29.6
54 45 1.37 1.19 -13.1
49 53 1.60 1.33 -16.9
23 42 1.39 1.15 -17.3
45 30 1.56 1.30 -16.7
45 52 1.77 1.58 -10.7
44 39 1.21 0.86 -28.9
44 39 1.76 1.19 -32.4
55 78 1.85 1.53 -17.3
57 60 1.26 1.11 -11.9
28 57 2.31 1.79 -22.5
19 50 1.74 1.51 -13.2
51 31 1.65 1.46 -11.5
21 72 1.47 1.28 -12.9
27 46 1.58 1.38 -12.7
25 40 1.28 1.01, -21.1
22 88 1.51 1.36 - 9.9
53 86 1.74 1.62 - 6.9
31 48 1.13 1.01 -10.6
17 75 2.15 1.85 -14.0
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Table 12 Individual values of (Na"*", KT) ATPase activity (poles Pi, mg protein hr ^) and












Controls (range) 17 - 62 30 - 88 1.08 - 2.55 0.75 - 2.19 -4.8 to -32.4
Definite/Probable
Ca rriers
3. I 48 344.0 1.38 1.35 - 1.4




32 41.0 1.14 0.89 -21.9
2. 11 - 29 55.0 1.17 0.93 -20.5
5. 1
2
41 36.0 1.29 1.19 - 7.8
6. 1 2 39 82.0 1.09
1.00 - 8.3
8. II 3 30 37.0 1.11 0.90 -18.9
11. 1 j 47 38.0 1.37 1.37 0
12. 11 , 37 53.0 1.78 1.70 - 4.5
14. I
j
50 60.0 1.33 1.32 - 0.8
16. m1
17. I 2
31 90.0 1.35 1.41 + 4.4
31 59.0 1.08 1.05 - 2.8
18. II 2 51 192.0 1.34 1.25
- 6.7





17 5p.O 1.03 0.98 - 4.9
6. II 3 15 88.5 0.89 1.02
+14.6
6. II 4 14 53.0 0.99
1.01 + 2.0
7. II 24 642.0 1.01 0.92 - 8.9
9. ii; 26 46.0 1.43 1.57 + 9.8
12. III5 16 95.5 1.23 1.60 +30.1
13. II 1 18 840.0 1.83 2.07 +13.1
14. II
2
20 20.0 1.46 1.32 - 9.6
15. II 1 23 355.0 1.57 1.73 +10.2
17. 11 3 3 58.0 1.16 1.13
- 2.6
18. III2 24 34.0 1.35 1.26 - 6.7
Other Female
Relatives
10. II 7 30 39.5 1.29 1.24
- 3.9
16. II - 67 358.0 1.37 1.43 + 4.4
77 148.5 1.68 1.46 -13.1
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Figure 10 Histogram of (Na+, K+) ATPase activity in carriers
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sisters and other female relatives however, the responses were
less consistent. Some preparations were inhibited as normal, whilst
others were inhibited less and stimulation occurred in several
cases (Table IX).
There was no correlation between (Na+, K+) ATPase activity
and SCK, age or % effect of ouabain, nor was the effect of ouabain
correlated with SCK or age. Of the two definite carriers, one
had an abnormal response to ouabain below the normal range, the
other was normal. Five out of the 12 possible carriers had
abnormal responses to ouabain, either less inhibition or
stimulation. Seven out of the 11 sisters exhibited abnormal
responses as did two of the other female relatives.
However, there was no obvious relationship between (Na+, K+)
ATPase activity and response to ouabain with respect to carrier status.
Other Muscle Diseases
The (Na+, K+) ATPase activity of erythrocyte ghost membranes
from patients with a variety of other muscle diseases was consistently
inhibited by ouabain. The individual values are shown in Table 14.












































NO*Significantatp<0.05whecomp redthc ntrols **p<0.01 ***p<0.001


































































Incubation of plasma and ghost membranes
These experiments were designed to investigate the effects
of plasma incubation on ghost membranes (Naf, K+) ATPase
determined by the effect of ouabain on the enzyme.
Materials and Methods
1 ml of ghost membrane was incubated with 1 ml of plasma
for 2 hours at 37°C. 40 ml of lysis buffer was added and the
suspension centrifuged at 10 000 g for 30 minutes. The sedimented
ghost membranes were resuspended in 1 ml of lysis buffer and
stored at -23°C prior to ATPase assay.
Both stored and unstored plasma was incubated with stored
and unstored ghost membranes (-70°C and -23°C respectively), and
there was no detectable effect of storage. All samples were
stored for a maximum of seven days prior to examination, except
those plasma samples used as controls for the deproteination and
dialysis experiments. These samples were fresh (within 2 hours
of collection) and stored at 4°C whilst the other samples were
prepared.
Dialysis of plasma samples
Fresh plasma was used (within 2 hours of collection) in
this preparation. 1 ml of plasma was dialysed against 5 litres
of distilled deionised water at 4°C overnight. Then the dialysis
bag containing the sample was totally submerged in 20% polyetheleneglycol
at 4°C, thereby reducing the volume of the sample. After 2 hours
when the volume was slightly less than 1 ml the sample was removed,
made up to 1 ml with deionised distilled water, and incubated with
ghost membranes as previously described.
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Deproteination of plasma samples
Fresh plasma was used (within 2 hours of collection) in this
procedure. 3 ml of plasma was deproteinated in such a way that
the final filtrate contained proteins of molecular weight < 10 000.
This was achieved with two stages of ultrafiltration.
Firstly, proteins of m. wt.> 25 000 were removed by
centrifugation at 1 500 g through an ultrafiltration cone filter,
at 4°C. The second filtration was through a millipore cellulose
membrane, pore size 0.005 jjm, at 4°C under 7 bar pressure with
gaseous nitrogen.
The final filtrate was incubated with ghost membranes as
previously described.
Effects of plasma incubation on the response of ghost membrane
(Na+, K+) ATPase to ouabain
Ghost membranes viere prepared from one healthy donor, and
incubated with plasma samples from other controls and DMD patients.
-f- -j-
The effect of ouabain on the (Na , K ) enzyme was then measured.
These results are shown in Table 15. There was consistent ouabain
inhibition of the (Na+, K+) ATPase enzyme in ghosts that had been
incubated in control plasma (-7.4% + 3.49) whereas enzyme stimulation
was apparent in the membranes incubated in DMD plasma (+8.0% + 2.99).
The abnormal response of DMD (Na+, K+) ATPase to ouabain
was partially inhibited by incubation of DMD ghost membranes in
control plasma (Table 16). The mean stimulation prior to incubation
(+13.5 + 2.98) had been reduced (+1.8 + 1.77).
There was no obvious effect of DMD plasma incubation on other
DMD ghost membranes (Table 17).
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Table 15 Effect of ouabain on control ghost membrane (Na+, K+)
ATPase after incubation with plasma from DMD patients
and other controls.
% effect after incubation % effect after incubation
in DMD plasma (n = 7) in control plasma (n = 11)
+ 7.1 - 8.7
+ 5.8 - 9.0
+ 6.3 - 3.8
+ 4.8 - 6.5
+ 9.4 - 3.8






MEAN SD MEAN SD
+8.0 2.99 -7.4 3.49
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Table 16 Percent effect of ouabain (10 M) on DMD ghost membrane
(Na+, K+) ATPase (n = 8) after incubation in control













Table 17 Percent effect of ouabain (10 M) on DMD ghost membrane
(Na+, K+) ATPase (n = 7) after incubation with DMD











The effects of dialysis and deproteination of the DMD plasma
samples prior to incubation with the donor ghost membranes are
shown in Table 18. These results indicate a partial loss of effect.
2+ 2+
Ca , Mg , and total protein concentrations of plasma
2+ - 2+
The concentrations of Ca and Mg ions and total protein were
measured in patients with DMD and controls. These results are
expressed in Table 19. The individual values are shown in Table 20,
from which it will be seen that there was no significant difference
in the amounts of any of these between controls and patients.
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Table 18 Effects of ouabain (10 ^M) on (Na+, K+) ATPase
activity in ghost membranes from a control incubated
with plasma samples from patients with DMD (n = 8),
and after dialysis (n = 8) and deproteination (n = 3)
of DMD plasma. Results expressed as percent effect on
activity of exposure to ouabain.
DMD plasma Dialysed DMD plasma Deproteinated DMD plasma
+18.6 - 7.0
+ 7.0 -11.9
+ 9.3 - 8.8
+ 4.0 - 4.7
+8.1 - 8.2
+ 8.2 -16.1 - 6.5
+11.3 -11.7 - 7.8
+ 6.6 -13.5 -11.5
MEAN SD MEAN SD MEAN SD
+9.1 4.37 -10.2 3.73 -8.6 2.59
2+
Table19Ca,Mgandtotalproteinlev lsip smafrDMD patientsndcontrols. Cammoles/1Mgmoles/1Pr t ing MeanSDMeanMeanSD DMD2.400 848.870 3 177.216.18(n=13)(n=10) Controls2.380 4870. 4.1287 .312. 1 (n=11)(n=11)
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2+ 2+Table 20 Individual values of Ca , Mg and total protein
concentrations in plasma samples from DMD patients.
DMD patient Ca (mmol/1) Mg (mmol/1) Protein (g/1)
(n = 13) (n = 13) (n = 10)
1. 11
3 2.60 0.91 77.0
2. III2 2.91 1.03 87.0
4. "4 2.28 0.86 75.0
11. II
2 2.40 0.80 75.0
12. II,7 2.41 0.86 -
16. 2.47 0.84 -
17. 1.86 0.68 70.0
18. UI4 2.51 0.93 76.0
19. III2 2.28 0.88 75.0
21. 2.28 0.85 -
22. 1113 2.48 0.95 85.0
24. II 2 2.34 0.81 74.0
25. 2.42 0.88 78.0
MEAN SD MEAN SD MEAN SD
2.40 0.848 0.87 0.301 77.2 16.18
Control Range 2.18 — 2.69 0.77 — 0.89 68.0 — 79.0
(n = 11)
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SDS - polyacrylamide gel electrophoresis
The effects of plasma incubation on the ghost membrane proteins
were studied using the technique of gel electrophoresis.
The method of gel preparation and run are outlined in
Appendix II (5% acrylamide with 0.2% SDS). The gels were photographed
with a Pentax Spotmatic camera, fitted with a 55 mm, fl.8 lens. The
gels were underlit, the aperture was f11, exposure time 1.0 second, using
Kodalith orthofilm type III, and an orange filter.
The protein profiles are shown in Plate 2. There were no
detectable differences, as investigated by a densitometric scan,
between the protein profiles of the DMD ghost membranes compared with
those of the control. Plasma incubation resulted in a marked alteration
in these protein profiles. However, there were no detectable differences
between the patterns which could be related to the source of the ghost
membranes or plasma samples.
Plate 2 SDS-PAGE protein profiles of ghost membranes from
DMD patient (A), control (B), DMD ghosts incubated in
DMD plasma (C), DMD ghosts incubated in control plasma (D) ,
control ghosts incubated in DMD plasma (E) and control
ghosts incubated in control plasma (F).
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Table 21 Published values of (Na+, K+) ATPase activity, (expressed as mean, SD prudes Pi,

































































































Klassen and Blostein (1969) and Pearson (1978) used a high
salt medium, with at least 50 mM NaCl, 10 mM KC1, 2 mM MgCl^,
in 50 mM Iris HC1. Several authors (Niebroj-Dobosz, 1976;
Mawatari et al. , 1976; Siddiqui and Pennington, 1977;
Wacholtz et al., 1979) have measured the (Na+, K+) ATPase activity
under both salt conditions. Niebroj-Dobosz (1976) and Siddiqui
and Pennington (1977) found a significantly higher (p<0.01)
activity under the 'high salt1 conditions. Mawatari et al., (1976)
reported a lower activity (p <0.01) in the 'high salt' medium,
and Wacholtz et al., (1979) found no difference.
Under the assay conditions employed the activity of the
ouabain sensitive (Na+, K+) ATPase was not the only enzyme measured,
2+
Mg ATPase activity would also be registered. By omitting K ions
2+
from the incubation media, the activity due to Mg ATPase alone
can be assayed. By subtracting the activities with and without
K+, the activity due to (Na+, K+) ATPase can be calculated. Hodson
and Pleasure (1978) and Pearson (1979) used this method to measure
the (Na+, K+) ATPase activity and its response to ouabain. Their
published results differ, in basal activity of control samples,
75 fold.
Some investigators included sucrose (0.25 M) in the incubation
mixture, which is believed to contain trace amounts of calcium.
In this case, the activity of the measured enzyme should rise, as
2+
the Ca ATPase will be activated, but there should be no effect
on the response to ouabain. There is no obvious correlation between
sucrose addition and greater enzymic activity. Incubation times
also vary, from 10 minutes to 60 minutes, during which time the
kinetics of the enzyme will change. However, the differences in
sucrose and metal ion concentrations on the incubation media,
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and assay time, are not sufficient to explain the wide variation
in published values of activity of the (Na+, K+) ATPase enzyme.
The variability is more probably due to the different methods
of ghost membrane preparation. Hanahan et al. , (1973) and
Hanahan and Ekholm (1978) have investigated (Na+, K+) ATPase and Ca"~+
ATPase activities of ghost membranes prepared by a variety of
techniques. Their results have illustrated the importance of
different lytic conditions on ghost membrane preparations for the
exposure and recovery of ATPase activity. The majority of investigators
who reported an abnormal response to ouabain, prepared the ghost
membranes by lysis in Tris buffer, concentrations ranging from
1 mM to 10 mM, pH 7.4, usually with the addition of EDTA. Subsequent
washings were in the same buffer with NaCl added. The basal activities
measured under this basic method of preparation, however, vary
-1 -1
from 0.85 to 25.1 ^imoles Pi, mg protein , hr .
Klassen and B1ostein (1969) lysed the erythrocytes in distilled
water, and washed the ghosts in Tris HC1, pH 7.4, but without the
addition of NaCl. Despite the use of the same preparative technique,
the basal activity of the enzyme from control ghosts reported by
Klassen and Blostein in 1969 was three times greater than that
published by Blostein in 1968.
Ruitenbeek (1979) used 172 mM Tris, pH 7.6, and also excluded
NaCl from the buffer for subsequent washings of the ghost membranes.
Hodson and Pleasure (1978) haemolysed the erythrocytes in NaCl
solutions of varying isotonic strengths in Tris maleate buffer, pH 7.6.
Wacholtz et al., (1979) reported preparing ghost membranes
by the different methods of Brown et al., (1967) and Blostein (1968).
The enzymic activity of each preparation was measured by both
assay techniques. In all cases the response to ouabain was normal.
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However, the B1ostein method resulted in a normal ghost membrane
(Na+, K+) ATPase activity of 0.464/vmoles Pi, mg protein \ hr ^,
whereas Klassen and B1ostein (1969) reported activity of 1.52 ^imoles
Pi, mg protein \ hr ^. The activity of the Brown procedure was
0.253 ^jmoles Pi, mg protein \ hr \ whilst Brown et al., (1967)
published their basal activity as 25.1 ^imoles Pi, mg protein \ hr \
The mechanism by which ouabain inhibits (Na+, K+) ATPase is
unknown. Albers et al., (1968) suggested a model for (Na+, K+)
ATPase action and postulated that ouabain acted at the dephosphorylation
stage of the K+ bound enzyme. The cardiac glycoside was believed
to lower the free energy difference between the phosphorylated and
dephosphorylated forms of the enzyme, or induce a change in the
conformational potential of the system. Siegel et al., (1969)
postulated that the enzyme - ouabain complex had a higher stability
than the enzyme alone in either of its phosphorylated or dephosphorylated
forms. By binding with the (Na+, K+) ATPase and reducing the energy
difference, ouabain would inhibit the transport of Na+ and K+ across
the membrane.
The 'local' concentrations of Na+ and K+ have an effect on
ouabain binding. Increases in Na+ concentration directly resulted
in an increased rate of ouabain binding, whilst K ions were clearly
antagonistic to the formation of the cardiac enzyme complex,
(Gardner and Conlon, 1972). These authors suggested that there
were a finite number of receptors in the cell surface, each composed
of a glycoside binding site and a cation binding site. Na+ and K+
competed for the cation binding site, thereby affecting the ouabain
affinity. Lindemayer and Schwartz (1973) also considered that
Na and K ions competed for one site. However, Hobbs and Dunham (1978)
concluded that there were two sites at which the alkali metal ions
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could exert effects on ouabain binding. External Na ions
facilitated ouabain binding, whatever the concentration of K+,
but the kinetics were different from inhibition of the K+ pump
by Na ions alone. K, Li and Cs ions, in the presence of Na+,
decreased ouabain binding. However, in the total absence of Na+,
only K+ inhibited ouabain complexing with the enzyme, both Li+
and Cs+ promoted glycoside binding. The authors suggested one
ouabain binding site was the loading area from which K ions were
translocated inward, and the other site was that from which Na
ions were discharged after outward translocation.
Lishko et al., (1972) reported that Pi increased the rate of
2+
ouabain binding in the presence of Mg and that this effect was
antagonised in the presence of K ions. Van Winkle et al., (1972)
suggested that this ouabain - enzyme complex formed in the presence
2+
of Pi and Mg may represent a different conformation than that
+ 2+
formed in the presence of ATP, Na and Mg . This may have been
due to different levels of enzyme phosphorylation, or enzyme
conformation prior to binding.
Taniguchi and Iida, in 1972, reported that there were two
related sites for the binding of ouabain, one with a higher
affinity for the glycoside than the other. This was ascertained
by varying the concentrations of ouabain and studying the effects
on the (Na+, K+) ATPase enzyme. Further evidence was published
by the same investigators in 1973, when they found that phospholipase
A differentially affected the high affinity site, where the ouabain-
2+
enzyme complex was induced by the presence of Mg and Pi. Heller
and Beck (1978) confirmed these findings, and described two ouabain
binding sites. Type I was detected at very low concentrations of
-9
ouabain (10 M), was not easily saturated (concentrations greater
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-3 +
than 10 M necessary) and was suggested to be the K insensitive
2+
site. Type II required the inclusion of Mg and Pi to form
complexes with ouabain, and was saturated at 10 ^ M ouabain, and
was reported to be the K+ sensitive site of the intact cell.
This recent evidence suggests that there are two sites
at which ouabain complexes with the (Na+, K+) ATPase enzyme. At
one of the sites, ouabain binding is facilitated by Na+, and
2+ 2+
requires ATP and Mg , whilst at the other site Mg and Pi are
prerequisites. Binding at this second site is antagonised by K ions.
Albers et al., (1968) reported a very slow rate of ouabain
combination with (Na+, K+) ATPase. This binding is controlled
not only by the conformation of the enzyme but also the balance
2+
of Pi to ATP, Na to K ions, and the concentrations of Mg and
2+
Ca present. The action of these three effectors could be
explained in model terms, by loosening or tightening some form
of steric barrier which would alter the rate of ouabain binding.
However, once formed, the ouabain enzyme complex is very stable.
This binding induces a conformational change that the uncomplexed
enzyme never exhibits. Farley (1979) investigated the action
of chymotrypsin and trypsin on (Na+, K+) ATPase before and after
ouabain binding. No cleavage products were found before or after
incubation with ouabain with trypsin. However, chymotrypsin treatment,
subsequent to ouabain binding, resulted in the cleavage of the
glycoprotein associated with the (Na+, K+) ATPase enzyme. One of
the catalytic subunits was also altered in the presence of ouabain.
The chymotrypsin treatment resulted in the further cleavage of one
of the fragments which was produced in the absence of the glycoside.
It can be concluded that ouabain binding resulted in a cleavage site
previously hidden, becoming accessible to protease action.
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Zachowski et al., (1977) reported that a protein or proteins
(m. wt. 30 000) on the inside of the plasma membrane may exert
+ +
some effect on the accessibility of the (Na , K ) ATPase to ouabain
action. Ouabain does not usually have access to the inner surface
of the membrane in vivo. However, with the technique of resealing
ghost membranes, it is possible to prepare 'inside out' vesicles,
where the previously inaccessible inside membrane becomes the
outer face of a resealed vesicle. EDTA treatment, which elutes
35% of the total membrane proteins, resulted in the 'inside out'
vesicles becoming 350 times more sensitive to the action of ouabain.
There was no change in the 'right side out' vesicles. Addition
of the eluted proteins to the stripped 'inside out' vesicles resulted
in restoration of the original resistance to ouabain. The proteins
which were detached from the inside of the membrane were probably
distinct from the (Na+, K+) ATPase but may still have exerted some
effect on the enzyme, perhaps in the form of a steric barrier.
Erdmann and Hasse in 1975, studied the quantitative aspects
of ouabain binding to human erythrocyte membranes. They reported
the binding was a time and temperature dependant process, and
speculated that there were in the region of 200 - 256 receptor
sites per erythrocyte. If there was equal distribution, this
2
would mean each site occupied less than 1 yum of surface membrane
area. However, Joiner and Lauf (1978) used whole erythrocytes and
calculated between 450 and 500 sites per cell. This discrepancy
may be due to the use of whole erythrocytes in one case and ghost
membranes in the other. Preparation of the ghost membranes could
have caused the inactivation of several receptor sites, but this
is unlikely to account for the complete difference.
The proteins of the erythrocyte membrane can be separated,
under certain conditions of gel electrophoresis, by molecular
+ +
size and charge. (Na , K ) ATPase migrates with band 3 proteins,
as do the other enzyme systems associated with transmembrane
ion transport. SDS gel electrophoresis has failed to show any
major differences in the profiles of ghost membranes prepared
from DMD patients compared with controls (Roses et al., 1975).
This suggests that there have been no significant alterations
in the structure of the membrane proteins in DMD. However,
Das et al., (1976) have observed different protein profiles in
triton treated ghosts from patients with DMD on slab gel electrofocusing.
The activity of the (Na+, K+) ATPase enzyme is dependent upon
the environment in the membrane. The hydrophobic nature of the
surrounding lipids, as well as the balance between the fluid and
crystalline states, are of importance. The fluidity of the membrane
may be an important determinant of lipid-protein interactions
and may also influence protein-protein interactions, thereby
affecting the function of the intermembrane transport systems.
t
Alterations in cholesterol content and fatty acid composition of
the phospholipids have been reported (Kunze et al., 1973; Howland
and Iyer, 1977). However, the evidence of changes in the lipid
composition of the erythrocyte membrane in DMD is contradictory
(Introduction II). Although such alterations could explain the
changes in basal activity, it is more difficult to interpret the
abnormal response to ouabain.
A small change of amino acid sequence could result in an
alteration of enzymic activity without affecting the physical
characteristics of the protein. A substitution along the amino acid
backbone of the protein could alter the configuration of the enzyme,
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and indirectly affect the receptor and active sites. However,
the substitution could occur at the receptor or active site,
directly altering the ability of the enzyme to recognise and
successfully bind its substrates, cofactors and inhibitors. In
this way, the basal activity of (Na+, K+) ATPase could be altered,
and the abnormal response of the enzyme to one of its inhibitors,
ouabain, explained. The different configurations that the enzyme
displays during its catalytic cycle may be unable to complex with
ouabain, although this would fail to explain a stimulation of
activity. However, ouabain may be irreversibly bound to a
receptor site, inducing a local conformational change in the
vicinity of the active site, and thereby make the active site
more recognisable or accessible to the substrate or cofactors. The
directional nature of the (Na+, K+) ATPase would almost certainly
require movement of the enzyme within the membrane. The binding
of ouabain, with a possible subsequent local configurational change,
may remove some form of steric barrier to this enzymic movement.
However, the finding that incubation of normal ghost membranes
in DMD plasma elicits an abnormal response of ghost (Na+, K+) ATPase
to ouabain suggests that some fraction in DMD plasma may be responsible
(Peter et al., 1969; Siddiqui and Pennington, 1977). After incubation
in plasma, the profiles of the ghost membrane proteins showed an
obvious shift in band 3. This was apparently the same whatever
the source of ghost membranes or plasma. The partial reversal of
ouabain effect on DMD ghosts by incubation in control plasma was
unusual. This suggested that the membrane was capable of reverting
back to a 'normal' condition once the 'factor' in the plasma was
removed.
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This so called 'circulating plasma factor1 was rendered
inactive by dialysis and deproteination of the plasma. This
suggests that the 'factor' is a protein which may require ions
for activation. However, there was no significant difference
in the calcium or magnesium concentrations or level of total
proteins in the DMD plasma.
The effect of the 'circulating plasma factor' however, does
tend to rule out the possibility of an amino acid substitution
in the enzyme, unless the action of the 'factor' on the membrane
elicits a similar response by a different mechanism. The
evidence does, on the other hand, suggest that there may be some
form of steric barrier affecting normal functioning of (Na+, K+)
ATPase of ghost membranes in DMD patients. This barrier inhibits
normal activity of the enzyme in DMD under certain conditions.
The binding of ouabain alters the barrier in such a way as to
promote enzymic activity. The incubation in control plasma removes
the barrier, but may do so by affecting the membrane as a whole,
as shown by SDS gel electrophoresis. The 'circulating plasma factor'
in DMD may be a protein which binds to the control membrane and
thereby induces a conformational change near the enzyme. This
would, in turn, elicit the abnormal response, as with the DMD
ghost membranes.
The abnormal ouabain responses of control ghost membrane
(Na+, K+) ATPase elicited by incubation in DMD plasma does not
support the theory that the pathogenesis of DMD is a primary
generalised membrane abnormality. Also, the partial reversal of
the abnormal ouabain effect in DMD ghost membranes after incubation






This study was designed to investigate certain properties
of the erythrocyte membrane in human muscular dystrophies, particularly
Duchenne muscular dystrophy, the most severe and common form.
Echinocyte and stomatocyte formation in patients with DMD was
not significantly different from in controls. This suggests that
if there were any alteration in the deformability of the erythrocyte
membrane, the conditions of preparation in this study were not
such as to induce the abnormality. However, erythrocytes from
patients with DMD were found to be osmotically more fragile than
those from controls. This was particularly obvious in the threshold
of lysis region.
Investigations into the activity and properties of the ghost
membrane (Na+, K+) ATPase enzyme were of most interest. In DMD
patients, basal activity was lower than in controls, and the cardiac
glycoside ouabain had a stimulatory effect on the enzyme, whereas
in controls (Na+, K+) ATPase was inhibited by ouabain. However,
this abnormal response to the cardiac glycoside was induced in
control ghost membrane preparations by prior incubation in Duchenne
plasma. This suggests that there is a possible 'circulating plasma
factor' effect in DMD. Dialysis and deproteination of the Duchenne
plasma resulted in partial loss of effect. After incubation of
DMD ghost membranes in control plasma (Na+, K+) ATPase stimulation
by ouabain was reduced. This suggests that if the abnormal response
obtained in DMD erythrocytes is due to a plasma factor then the
effect is at least partially reversible.
SDS - PAGE failed to reveal any significant differences
between the protein profiles of DMD and control ghost membranes. .
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Incubation in control and Duchenne plasma resulted in major changes
of these protein profiles, but these alterations were not
significantly different between the DMD and control ghost membranes.
The results of the present investigation add evidence to the
theory of a generalised membrane defect in DMD. However, the fact
that there may be a 'circulatory plasma factor' in patients which
can induce comparable changes in normal cell membranes, raises
the possibility that some of the observed membrane changes in DMD
may, in fact, be secondary to the disease process and not necessarily
a reflection of a primary defect.
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Echinocyte and stomatocyte investigations
Sodium chloride (0.9%)





dissolve 9.0 g NaCl in 1 litre H^O
dissolve 2.1402 g sodium
cacodylate trihydrate
in HpO, make up to 950 ml
and adjust pH to 7.4 with
HC1. Make up to 1 litre.
dilute 1.2 ml gluteraldehyde
(special electron microscope
grade - 25%) to 10 ml with
10 mM cacodylate buffer.
dissolve 10 g sucrose in
cacodylate buffer, make up to
100 ml with buffer.
- dissolve 13.65 g Na^HPO, and
2.43 g NahLPO, . 2H-0 in 1 litre
of H20. Bring to pR 7.4.
Add 90 g NaCl. Solution
osmotically equivalent
to 100 g/1 NaCl. Dilute with
H20 for specific concentrations.
Store at 4°C for one month.
Erythrocyte ghost membrane preparation
Hypotonic haemolysis buffer





- dissolve 1.211 g Tris in 1 litre
Hp0. Bring to pH 7.4 with HC1.
Add 0.0584 g NaCl, 0.2033 g
MgCK, 0.0746 g KC1 and 0.1543 g
dithtothreitol. Check pH.
Store at 4°C for one month.
- dissolve 0.9 g NaCl and 0.5 g NaOH
in 100 ml H„0. Store at 4°C for
one month.
- dissolve 20 g Na„ CO, in 1 litre
0.1 M NaOH. Store at 4°C for
two weeks.
- dissolve 2 g KNa tartrate and
1 g CuSO, . 5H20 in 100 ml H^O.













- 1 ml of reagent II with
50 ml of reagent I.
Prepare fresh.
- Folin - Ciocalteu reagent
diluted 1:1.1 with HpO.
Prepare fresh.
- dissolve 10 mg of bovine
serum albumin in 10 ml PSF.
Concentration 1 mg/ml. Dilute
with PSF for protein
calibration curve. Store at
4°C for two weeks.
- dissolve 5 g in 10 ml H^O
- dissolve 25 g ammonium
molybdate in 200 ml H?0.
Add 500 ml 5 M HpSO. and make
up to 1 litre with HpO.
- dissolve 25 g ammonium
molybdate in 200 ml H90.
Add 300 ml 5 M HpSO. and
make up to 1 litre with HpO.
- dissolve 3.0 g NaHSO, in 200 ml
H„0. Prepare and stand for
two days before use.
- dissolve 200 g NapSO- . 7H?0
in 380 ml HpO. Filter and
keep well stoppered.
- dissolve 0.5 g of the dry
powder in 195 ml sodium
bisulphite solution, add 5 ml
sodium sulphite solution. Store
in dark bottle for up to one
month at 4°C.
- dissolve 0.351 g KHpPO. in
100 ml HpO, add 10 mi 5 M HpSO.
and make up to 1 litre 11 4
with HpO. Solution keeps
indefinitely. Dilute standard
for use for phosphate calibration.
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10 X buffer, pH 7.4
(40 mM Tris, 20 mM sodium acetate








- dissolve 3.633 g Tris in
300 ml H?0. Bring to pH 7.4
with HC1T Add 0.0175 g NaCl,
0.0447 g KC1, and 0.0610 g
MgCl2. Check pH. Store at
4°C for one month. 4 mM
Na„ATP added to assay medium
immediately prior to incubation.
- dissolve 0.007 g in 10 ml H^O.
Prepare fresh.
- dissolve 10 g acrylamide and
0.375 g bis-acrylamide in H?0
and make up to 25 ml. ~
- dissolve 24.2280 g Tris, 13.6080 g
sodium acetate, and 3.7224 g EDTA
in 200 ml H^O. Adjust to pH 7.4
with glaciaT acetic acid. Make
up to 500 ml with H^O.
- dissolve 0.0252 g bromophenol
blue in H^O and make up to 50 ml.
- dilute 70 yl TEMED to 10 ml
with H^O
- dissolve 0.1500 g ammonium
persulphate in 10 ml H^O
- 10% SDS (according to concentration
used in gel; 0.2 ml for 0.2% run),
with 1 ml anmonium persulphate
(1.5%), 0.5 ml TEMED (0.7%) and
8.3 ml H^O.
- to 90 ml 10 X buffer add 18 ml
SDS (10%) for 0.2% run and make
up to 900 ml with H^O.
- dissolve 0.0500 g coomassie blue
in 25 ml propanol. Add 65 ml
H^O; and 10 ml acetic acid before use
- mix 2.50 ml concentrated acrylamide
bis-acrylamide solution, 2.00 ml
10 X buffer and 12.10 ml H20.
De-airate. Add 0.40 ml SDS (10%)
for 0.2% run, 2.00 ml ammonium
persulphate (1.5%) and 1.00 ml
TEMED (0.7%).
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SDS - PAGE protein solubi1ising fluid
(10 mM Tris, 20% sucrose, 1 mM
EDTA and 80 mM dithiothreitol)
dissolve 0.0484 g Tris,
4.000 g sucrose, 0.0148 g
EDTA and 0.2468 g dithiothreitol
in 17.18 ml H^O, adjust to pH
8.0 and make Dp to 20 ml with H^O.
METHOD
Polyacrylamide gel solution was poured into 6.5 cm gel tubes. The
gels were overlayed with PAGE solution for 40 minutes whilst polymerisation
occurred. The overlay solution was then removed and the top of the
gels washed three times in 10 X buffer. The SDS - PAGE PSF containing
ghost membrane protein was incubated in a boiling water bath for three
minutes, then cooled in ice. 50 pi (containing 3 pi 0.05% bromophenol
blue and ghost membrane protein to a final concentration of 1 mg/ml) was
layered onto each gel, and covered with electrophoresis buffer. A
current of 2 mA/tube was applied until the samples ran into the gel, when
the current was increased to 6 mA/tube. The duration of the run was
approximately three hours. The gels were removed from the glass tubes,
and stained in coomassie blue overnight. The gels were destained in
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Osmotic fragility of erythrocytes
in Duchenne muscular dystrophy
Duchenne muscular dystrophy is an X-linked recessive disorder
affecting young boys. It is one of the more severe forms of muscular
dystrophy and is transmitted by healthy female carriers. Onset is
usually at 3-5 years and affected individuals become chairbound by
the end of the first decade. Death occurs in the late teens or early
twenties from cardiac failure or pneumonia. The basic defect in this
disorder is as yet unknown but several recent studies1^4 have suggested
that there may be a generalised membrane abnormality affecting
erythrocytes as well as muscle. Fisher et al4 have reported an increase
in the osmotic fragility in cases of what they refer to as "pseudo¬
hypertrophic muscular dystrophy." We report here our findings in a
series of 10 patients with confirmed Duchenne muscular dystrophy
and four definite carriers. (A definite carrier is defined as the mother
of an affected boy with another affected male relative. The four
carriers studied here had serum creatinine kinase levels of 83, 132,
213, and 344 IU/1 (normal upper limit 85 IU/1).)
Patients, methods, and results
Heparinised samples of venous blood were obtained from patients (aged
1-18), their unaffected brothers (aged 1-16), and female carriers (aged 23-56)
when the families attended the muscular dystrophy clinic in the department.
Control samples were obtained from young boys (aged 4-15) before ortho-
Per cent lysis (mean ± SD) in male controls, boys with Duchenne muscular
dystrophy (DMD), their unaffected brothers, female controls, and definite
carriers
Sodium Male DMD Female Definite
chloride controls patients Brothers controls carriers
concentration (n = 10) (n = 10) (n = 5) (n = 36) (n = 4)
(g/n
10 100 100 100 100 100
3 6 951 ±2-9 94 4 ± 5 9 93-4 ±6 0 95-5 ±3-6 91-6 ±2-8
3-8 90-7±30 91 2 ±7-2 83-4 ±132 89-9 ±85 86-5 ±3-5
40 79 4±12 5 83 4± 13-6 63 6±18-3 78-8 ±14-4 75-7 ±11-7
4-2 50-7 ±17-6 667 ± 18 3 38 5 ±11-9 64-4 ±181 49-5 ±201
4-4 139 ±9-9 340 ± 19-6 9*5 ±21 40-4 ± 17-7 181 ±14-9
4 6 4-5 ±4-2 163 ± 130 4-6 ±2-1 18-6±ll-3 58 ±71
4-8 1-7 ± 1-8 6-9 ±7 0 1-3 ±07 6-8 ±6-7 21 ±3-3
50 00 1-3 ± 1-5 00 l-2± 1-9 00
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paedic operations for disorders unrelated to neuromuscular abnormalities
and healthy women volunteers (aged 17-67). The amount of lysis at various
concentrations of sodium chloride was determined by the method of Dacie
and Lewis.5 The concentrations of sodium chloride resulting in 50% lysis
of each sample were derived graphically.
Signs of lysis first became apparent in affected boys at a concentration of
5 0 g/1 but in the controls and normal brothers at a concentration of 4-8 g/1.
At all concentrations of sodium chloride from 4-4 to 5 0 g/1 (see table) there
was significantly greater lysis in affected boys than in either their unaffected
brothers or controls (P<005). The concentration (mean ±SD) of sodium
chloride which resulted in 50% lysis was 4-18 ±0-10 g/1 for male controls,
4-30±0-13 g/1 for affected boys, and 4 08±0* 12 g/1 for their unaffected
brothers, the difference between affected boys and either their unaffected
brothers or controls being statistically significant (P<005). There was no
difference in erythrocyte osmotic fragility between definite carriers and the
control series of normal women.
Comment
These results provide additional evidence that there is a probable
defect in the erythrocyte membrane in patients with Duchenne
muscular dystrophy.
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